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1. INTRODUCTION 
                 Pharmaceutical Analysis may be defined as the application of analytical 
procedures used to determine the purity, safety and quality of drugs and chemicals.  The 
pharmaceutical analysis comprises the procedures necessary to determine the “identity, 
strength, quality and purity” of such compounds. It also includes the analysis of raw material 
and intermediates during manufacturing process of drugs. 
1.1. TYPES 1 
            Pharmaceutical analysis includes both qualitative and quantitative of drugs and 
pharmaceutical substances starts from bulk drugs to the finished products. 
1.1.1. Qualitative analysis 
▪ Qualitative inorganic analysis seeks to establish the presence of a given element or 
inorganic compound in a sample. 
▪ Qualitative organic analysis seeks to establish the presence of a given functional 
group or organic compound in a samples 
1.1.2 Quantitative analysis2 
Quantitative analysis seeks to establish the amount of a given element or compound in 
a sample. 
            Importance of analytical chemistry is to gain information about the qualitative and 
quantitative composition of substance and chemical species, that is, to find out what a 
substance is composed of and exactly how much it is present 
            For the past two decades, the pharmaceutical analyst has been a spur in development 
of analytical techniques for various medicinal principles both in pure and combined state and 
also in finished products. Some of the methods shine in modern technological and electronics 
and microprocessor-based developments have really shown faster and best results with more 
accuracy than the conventional methods. 
             There are various methods used for quantitative analysis of mixtures. One of them is 
spectrophotometry, which utilizes the measurement of intensity of electromagnetic radiation 
emitted or absorbed by the analyte. Another technique which has gained large popularity 
during last decade is high performance liquid chromatography. The technique is very much 
useful to pharmaceutical analyst in analyzing complex formulation containing number of 
ingredients as it permits simultaneous separation and determination of components of 
mixture. 
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1.2. METHODS OF ANALYSIS  
1.2.1. Generally analytical methods are classified as follows: 
1. Chemical methods 
2. Instrumental methods 
a) Chemical methods 
1. Volumetric method 
2. Gravimetric method 
b) Instrumental methods: 
           The analytical chemist, to save time, to avoid chemical separation or to obtain 
increased accuracy may use instrumental methods. This can be classified into: 
1. Spectrophotometric methods – UV, IR, NMR etc. 
2. Fluorimetric methods 
3. Polarimetric method 
4. Flame photometric method 
5. Turbidimetric method 
6. Chromatographic method 
7. Refractrometric method 
8. Thermal method 
9. Electro chemical method 
1.3. INTRODUCTION TO CHROMATOGRAPHY3 
              The word is obtained from the Greek word chroma + graphia, literally "colour 
writing". Chromatography is a technique for analyzing mixtures of gases, liquids or solutes 
by exploiting differences in their distribution between a stationary and a mobile phase. 
Chromatography is a fundamental technique in the detection, identification and quantization 
of chemical species. It comes in two basic formats, planar and column chromatography. 
1.3.1. Classification of chromatography based on stationary phase 
1.3.1.1. Planar Chromatography 
The origins of planar chromatography can be traced back to the practice amongst 
dyers of testing pigments by placing a drop on paper and observing the colours as the drop 
spreads. The scientific use of paper chromatography can be traced to the mid-19th century. 
The important separation of amino acids and peptides by paper chromatography was 
developed in 1994 by Consden, Gordon, and Martin. Thin layer chromatography (TLC) was 
developed in 1938 by Izmailov and Shraiber based on Mikhail Tswett’s earlier description of 
column chromatography. 
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1.3.1.2. Column Chromatography 
Russian botanist Mikhail Tswett’s invented column chromatography in 1906 as a 
means of studying plant pigments, but it soon became clear that the technique provided a 
means for separating many complex homogeneous mixtures into their individual components. 
Today instrumental chromatographic techniques are essential tools in areas such as 
chemistry, biology, medicine, forensic science, manufacturing and the environment.  
Table 1 Classification of column chromatographic methods 2 
General 
Classification 
Specific 
Method 
Stationary 
Phase 
Type of 
Equilibrium 
Liquid 
Chromatography 
(LC) (mobile phase: 
liquid) 
Liquid-Liquid  
or partition 
Liquid adsorbed 
on a solid 
Partition between 
immiscible 
liquids 
Liquid-Bonded 
phase 
Organic species 
bonded to a solid 
surface 
Partition between 
liquid and bonded 
surface 
Liquid-Solid or 
adsorption 
Solid Adsorption 
Ion exchange 
size exclusion 
Ion-exchange 
resin Liquid in 
interstices of a 
polymeric solid 
Ion exchange 
Partition/sieving 
Gas Chromatography 
(GC) (mobile phase: 
gas) 
Gas-liquid 
Liquid adsorbed 
on a solid 
Partition between 
gas and liquid 
Gas-bonded 
phase 
Organic species 
bonded to a solid 
surface 
Partition between 
liquid and bonded 
surface 
Gas-Solid Solid Adsorption 
Supercritical-fluid 
chromatography 
(SFC) (mobile phase: 
Super critical fluid) 
 
Organic species 
bonded to a solid 
surface 
Partition between 
supercritical fluid 
and bonded 
surface 
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1.3.2. Classification of chromatography based on mobile Phase 
           Chromatographic methods are also classified depending upon the medium of the 
mobile phase. There are two methods under this category: 
1.3.2.1. Gas chromatography 
            Gas chromatography (GC) is based on a partition equilibrium of analyte between a 
solid stationary phase (often a liquid silicone-based material) and a mobile gas (most often 
Helium). The stationary phase is adhered to the inside of a small-diameter glass tube (a 
capillary column) or a solid matrix inside a larger metal tube (a packed column). It is widely 
used in analytical chemistry; though the high temperatures used in GC make it unsuitable for 
high molecular weight biopolymers or proteins (heat will denature them), frequently 
encountered in biochemistry, it is well suited for use in the petrochemical, environmental 
monitoring and remediation, and industrial chemical fields. It is also used extensively in 
chemistry research. 
1.3.2.2. Liquid chromatography 
            Liquid chromatography (LC) is a separation technique in which the mobile phase is a 
liquid. Liquid chromatography can be carried out either in a column or a plane. Present day 
liquid chromatography that generally utilizes very small packing particles and a relatively 
high pressure is referred to as high performance liquid chromatography (HPLC). 
1.3.2.3. Supercritical Fluid Chromatography (SFC) 
           SFC is a separation technique in which the mobile phase is a fluid above and relatively 
close to its critical temperature and pressure.  SFC is a form of normal phase chromatography 
that is used for the analysis and purification of low to moderate molecular weight, thermally 
labile molecules. It can also be used for the separation of chiral compounds. Principles are 
similar to those of high performance liquid chromatography (HPLC), however SFC typically 
utilizes carbon dioxide as the mobile phase; therefore the entire chromatographic flow path 
must be pressurized. 
1.3.3. Classification of chromatography based on the mechanism of separation4      
1.3.3.1. Adsorption chromatography 
 It involves the interaction between the sample molecule and the stationary phase. It is 
a competitive situation in which the molecules of the mobile phase and the solute are in 
competition for discrete adsorption sites on the surface of the column. Interaction between a 
solute molecule and the adsorbent surface is optimum when solute functional groups exactly 
overlap these adsorption sites. The adsorbent may be packed in a column e.g. silica, alumina. 
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The separation is achieved by changes in the composition of mobile phase. It is used for 
analysis of non-ionizing, water insoluble compounds. 
1.3.3.2. Bonded phase chromatography 
It is widely used column packing for liquid-liquid partition chromatography with 
chemically bonded, organic stationary phases. Partition occurs between the bonded phase and 
a mobile liquid phase. Bonded phase supports are made from silica by the covalent 
attachment of an organic hydro carbon moiety to the surface. A stationary phase chemically 
bonded to a support that is used for the separation. It is the most commonly used LC mode. 
The most popular support used is micro particulate silica gel. An organosilane, such as 
octadecyl (for reversed-phase chromatography) is the most accepted type of bonded phase. 
 1.3.3.3. Normal phase chromatography 
 Also known as Normal phase HPLC (NP-HPLC), in this method separation of analyte 
is based on polarity, it was the first kind of HPLC that chemists developed.  NP-HPLC uses a 
polar stationary phase and a non-polar mobile phase and works effectively for relatively polar 
analyte. The polar analyte associates with and is retained by the polar stationary phase. 
Adsorption strength increase with increased analyte polarity and the interaction between the 
polar analyte and the polar stationary phase (relative to the mobile phase) increases the 
elution time.  
1.3.3.4. Size exclusion chromatography (SEC) 
It is a chromatographic method in which particles are separated based on their size or 
in more technical terms their hydrodynamic volume. It is usually applied to large molecules 
or macromolecular complexes such as proteins and industrial polymers. When an aqueous 
solution is used to transport the sample through the column the technique is known as gel 
filtration chromatography. The name gel permeation chromatography is used when an 
organic solvent is used as a mobile phase. The main application of gel filtration 
chromatography is the fractionation of proteins and other water-soluble polymers, while gel 
permeation chromatography is used to analyze the molecular weight distribution of organic-
soluble polymers. Polymer chemists typically use either silica or cross linked polystyrene 
medium under a higher pressure. This media are known as the stationary phase. 
1.3.3.5. Ion-exchange chromatography  
It is a process that allows the separation of ions and polar molecules based on the 
charge properties of the molecules. It can be used for almost any kind of charged molecule 
including large proteins, small nucleotides and amino acids. It is often used in protein 
purification, water analysis and quality control. Ion exchange chromatography retains analyte 
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molecules based on coulomb (ionic) interactions. The stationary phase surface displays ionic 
functional groups (R-X) that interact with analyte ions of opposite charge. This type of 
chromatography is further subdivided into cation exchange chromatography and anion 
exchange chromatography. The ionic compound consisting of the cationic species M+ and 
the anionic species B- can be retained by the stationary phase. 
 1.3.3.6. Bio-affinity chromatography 
This chromatographic process relies on the property of biologically active substances 
to form stable, specific and reversible complexes. The formation of these complexes involves 
the participation of common molecular forces such as the Van der Waals interaction, 
electrostatic interaction, dipole-dipole interaction, hydrophobic interaction and the hydrogen 
bond. An efficient bio specific bond is formed by a simultaneous and concerted action of 
several of these forces. 
 1.3.3.7. Hydrophobic Interaction Chromatography (HIC) 
Hydrophobic Interaction Chromatography is a separation technique uses the 
properties of hydrophobic to separate proteins from one another. In this type of 
chromatography, hydrophobic groups such as phenyl, octyl or butyl are attached to the 
stationary column. Proteins that pass through the column that have hydrophobic amino acid 
side chains on their surfaces are able to interact with and bind to the hydrophobic groups on 
the column. HIC separations are often designed using the opposite conditions of those used in 
ion exchange chromatography. In this separation, a buffer with a high ionic strength, usually 
ammonium sulfate is initially applied to the column. The salt in the buffer reduces the 
solvation of sample solutes thus as solvation decreases, hydrophobic regions that become 
exposed are adsorbed by the medium. The stationary phase is designed to form hydrophobic 
interactions with other molecules. 
Selection of suitable method for estimation of drug in dosage forms is an impending 
challenge for an analytical chemist. The method so selected should provide analytical data as 
accurate as required, technically sound, defensible with low level of uncertainty and above all 
amenable to routine laboratory use and capable of giving reproducible results. HPLC has 
become the back bone of the biotechnology and pharmaceutical industries where it is used to 
identify, characterize and purify molecules at all stages of a process, from R&D to quality 
assurance and validation. 
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1.3.4. Why HPLC   having high importance compared with other techniques? 
            Different types of chromatographic techniques are available to analyze the samples, 
but one of the technique very familiar, is High Performance Liquid Chromatography. HPLC 
technique is not only useful for separation, but also useful for qualifying (identifying) and 
quantifying the small and neutral molecules also. A few microgram of sample (at the 
extreme, even less than a nanogram) is enough to ensure the required accuracy. Secondly, 
HPLC separations are usually relatively fast, precise, accurate and an analysis can be 
completed in short span possibly in a few seconds. Another advantage of these techniques is 
relative simplicity and ease of operation compared with other instrumental techniques. If the 
established procedure is well controlled and the apparatus is maintained under calibrated 
condition, good accuracy and precision can be achieved. 
1.4. ANALYTICAL METHODS DEVELOPMENT 
              The number of drugs introduced into the market is increasing every year. These 
drugs may be either new entities or partial structural modification of the existing one. Very 
often there is a time lag from the date of introduction of a drug into the market to the date of 
its inclusion in pharmacopoeias. This happens because of the possible uncertainties in the 
continuous and wider usage of these drugs, reports of new toxicities (resulting in their 
withdrawal from the market), development of patient resistance and introduction of better 
drugs by competitors. Under these conditions, standards and analytical procedures for these 
drugs may not be available in the pharmacopoeias. It becomes necessary, therefore to develop 
newer analytical methods for such drugs.  
             Pharmaceutical products formulated with more than one drug, typically referred to as 
combination products, are intended to meet previously unmet patients need by combining the 
therapeutic effects of two or more drugs in one product. These combination products can 
present daunting challenges to the analytical chemist responsible for the development and 
validation of analytical methods.  
1.4.1 Basic criteria for new method development of drug analysis:  
➢ The drug or drug combination may not be official in any pharmacopoeias,  
➢ A proper analytical procedure for the drug may not be available in the literature 
due to patent regulations,  
➢ Analytical methods may not be available for the drug in the form of a formulation 
due to the interference caused by the formulation excipients,  
➢ Analytical methods for the quantitation of the drug in biological fluids may not be 
available,  
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➢ Analytical methods for a drug in combination with other drugs may not be 
available,  
➢ The existing analytical procedures may require expensive reagents and solvents. It 
may also involve cumbersome extraction and separation procedures and these may 
not be reliable.  
 
1.5. HPLC METHODS OF ANALYSIS FOR DRUGS IN COMBINATION 
             Most of the drugs in multi-component dosage forms can be analyzed by HPLC 
method because of the several advantages like rapidity, specificity, accuracy, precision and 
ease of automation in this method. HPLC method eliminates tedious extraction and isolation 
procedures. Some of the advantages are:  
➢ Speed (analysis can be accomplished in 20 minutes or less),  
➢ Greater sensitivity (various detectors can be employed),  
➢ Improved resolution (wide variety of stationary phases),  
➢ Reusable columns (expensive columns but can be used for many analysis),  
➢ Ideal for the substances of low volatility,  
➢ Easy sample recovery, handling and maintenance,  
➢ Instrumentation tends itself to automation and quantitation (less time and less 
labor),  
➢ Precise and reproducible,  
➢ Calculations are done by integrator itself,  
➢ Suitable for preparative liquid chromatography on a much larger scale.  
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1.6. HPLC METHOD DEVELOPMENT 5  
           HPLC method development seems complex. The process is influenced by the nature of 
the analytes and generally involves the following steps: 
 
 
 
 
 
 
 
 
  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Information on sample, define separation goals 
 
Need for special HPLC procedure, sample pretreatment etc., 
 
 
 
 
ple pre-treatment 
 
Choose detector and detector settings 
treatment 
 
Choose LC method – preliminary run; estimate best 
separation conditions 
treatment 
 
Optimize separation conditions 
treatment 
 
Check for problem or require for special procedure 
treatment 
 
Require purified material             Quantitative calibration and Qualitative 
method 
 Validated method for release to routine 
analysis method 
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1.7. INSTRUMENTATION OF HPLC2,3,4 
 The general instrumentation for HPLC incorporates the following components, 
• Solvent reservoir. 
• Pump. 
• Sampling valves or loops  
• Guard column  
• Pressure gauge  
• Analytical column 
• Detector  
• Data acquisition system 
 
 
Figure 1 Block diagram of a HPLC instrument 
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Figure 1 Schematic diagram of a HPLC instrument 
 
 
1.8. TYPES OF HPLC BASED ON MODES OF SEPARATION 
❖ NP-HPLC 
❖ RP-HPLC 
            
In the normal phase mode, the stationary phase is a polar substance such as 
polyethylene glycol or the untreated silica surface itself, and the mobile phase is non polar 
(e.g. hexane) under these circumstances polar compounds retarded preferentially and non 
polar substances elute more quickly.           
 In reversed phase mode, the stationary phase is non polar (e.g. ODS) and the mobile 
phase is polar, usually a mixture of water, methanol and/or acetonitrile. Non polar 
compounds are retained more strongly, while polar solutes elute first. Reversed phase 
separations are the most frequently used methods in HPLC.  
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Table 2 Comparison of NP – HPLC and RP – HPLC 
Parameter Normal Reversed 
Packing polarity High Low 
Solvent polarity Low High 
Elution order 
Non-polar first, then 
polar 
Polar first, then non-polar 
Effect of increasing 
solvent polarity 
Decreases retention 
time 
Increases retention time 
 
1.9. INTRODUCTION TO RP – HPLC6 
 Separation by RP – HPLC is similar to the extraction of different compounds from 
water into an organic solvent, where more hydrophobic (non - polar) compounds extract into 
the non - polar phase. The column (typically C8 and C18 bonded phase) is less polar than the 
water - organic phase. Sample molecules partition between the polar mobile phase and non – 
polar C8 and C18 stationary phase and more hydrophobic (non - polar) compounds are 
retained more strongly. Polar compounds are less strongly held and elute from the column 
first and vice versa. In RP – HPLC the retention of a compound is determined by its polarity, 
experimental conditions, mobile phase, column and temperature. RP – HPLC columns are 
efficient, stable and reproducible.    
1.9.1. Mobile phase effects 
 Retention is preferable adjusted by changing mobile phase composition or solvent 
strength. In this the retention is less for stronger, less polar mobile phase. Solvent strength 
depends on the choice of organic solvent and its concentration in the mobile phase. 
1.9.2. Mobile phase strength 
1. In RP-HPLC solvent strength varies as  
2. Water < Methanol < Acetonitrile < Ethanol < Tetrahydrofuran < Propanol < Methylene 
chloride.    
3. Acetonitrile is best initial choice of solvent and Acetonitrile and Water mixture used for 
UV detection.   
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1.10. VARIOUS METHODS OF QUANTITATIVE ANALYSIS IN HPLC    
              The sample or solute is analyzed quantitatively in HPLC by either peak height or 
peak area measurements.  Peak areas are proportional to the amount of constant rate.  Peak 
heights are proportional to the amount of material only when peak width are constant and are 
strongly affected by the sample injection techniques.  Once the peak height or the peak areas 
are measured, there are five principle evaluation methods for quantifying the solute3,7. 
1.10.1. Calibration by Standards 
 Calibration curves for each component are prepared from pure standards, using 
identical injection volumes of operating conditions for standards and samples.  The 
concentration of solute is read from its curve if the curve is linear. 
                          X = K x Area. 
Where, X = Concentration of solute. 
   K = Proportionality constant (slope of the curve). 
 In this evaluation method only the area of the peaks of interest is measured.  Relative 
response factors must be considered when converting areas to volume and when the response 
of a given detector differs for each molecular type of compounds. 
 1.10.2. Internal Standard Method 
In this technique a known quantity of the internal standard is chromatographed and 
area versus concentration is ascertained.  Then a quantity of the internal standard is added to 
the raw sample prior to any sample pretreatment or separation operations. 
 The peak area of the standard in the sample run is compared with the peak area when 
the standard is run separately.  This ratio serves as a correction factor for variation in sample 
size for losses in any preliminary pretreatment operations or for incomplete elution of the 
sample.  The material selected for the internal standard must be completely resolved from 
adjacent sample components, must not interfere with the sample components and must never 
be present in samples. 
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1.10.3. Area Normalization 
The technique is often used for the sample having identical components.  It is used to 
evaluate the absolute purity of the sample.  The procedure is to total up the areas under all 
peaks and then calculate the percentage of the total area that is contributed by the compound 
of interest.  For this method the entire sample must be eluted, all components must be 
separated and each peak must be completely resolved. 
 1.10.4. Standard Addition Method 
               If only few samples are to be chromatographed, it is possible to employ the method 
of standard addition(s). The chromatogram of the unknown analyte is recorded, then a known 
amount of analyte(s) is added and the chromatogram is repeated using same reagents, 
instruments and same conditions. From the increase in the peak area (or) peak height, the 
original concentration can be computed by interpolation. 
The detector response must be a linear function of analyte concentration and yield no signal 
at zero concentration of the analyte. Sufficient time must elapse between addition of the 
standard and actual analysis to allow equilibrium of added standard with any matrix 
interferon. 
If an instrumental reading (area/height) ‘Rx’ is obtained, from a sample of unknown 
‘x’ and a reading ‘Rt’ is obtained from the sample to which a known concentration ‘a’ of 
analyte has been added, then ‘x’ can be calculated from. 
 
 A correction for dilution must be made if the amount of standard added changes the 
total sample volume significantly.  It is always advisable to check the result by adding at least 
one other standard. 
 1.10.5. External Standard Method 
 It employs a separate injection of a fixed volume of sample and standard solution. The 
peaks are integrated and concentration is calculated. 
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The selection of suitable chromatographic (HPLC) system for a given mixtures of 
solutes cannot be made with certainty and must be confirmed by experiment.  If the chemical 
nature of the sample components is known, then the phase system can be selected from the 
literature references.   If nothing is known about the chemical nature of sample, then the 
sample solubility will give some indication as to which chromatographic method to employ. 
The essential parts of high performance liquid chromatographic system are solvent reservoir, 
pump, injection port, column, detector and recorders. 
1.11. METHOD VALIDATION 
         Method validation can be defined as establishing documented evidence, which   
provides a high degree of assurance that a specific activity will consistently produce a desired 
result or product meeting its predetermined specifications and quality characteristics. 
         Method Validation, however, is generally a one-time process performed after the 
method has been developed to demonstrate that the method is scientifically sound and that it 
serves the intended analytical purpose. 
1.11.1. Purpose of Validation 
➢ Enable the scientists to communicate scientifically and effectively on technical 
matter. 
➢ Setting the standards of evaluation procedures for checking compliance and 
taking remedial action. 
➢ Economic: Reduction in cost associated with process sampling and testing. 
➢ As quality of the product cannot always be assured by routine quality control 
because of testing of statistically insignificant number of samples. 
➢ Retrospective validation is useful for trend comparison of results compliance 
to CGMP/CGLP. 
➢ Closure interaction with Pharmacopoeial forum to address analytical 
problems. 
➢ International Pharmacopoeial harmonization particularly in respect of 
impurities determination and their limits. 
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1.11.2. Guidelines for method validation 7,8,9 
 
            ICH Method Validation 
 
  
 
 
 
 
 
 
 
 
 
         USP Method Validation 
 
 
 
 
 
 
 
 
 
 
 Typical validation characteristics which should be considered and their definitions are 
given below. 
1.11.2.1. Accuracy 
 The closeness of agreement between the value, which are accepted either as a 
conventional true value or an accepted reference value and the value found. Accuracy is 
represented and determined by recovery studies. 
1.11.2.2. Precision 
 The precision of an analytical procedure expresses the closeness of agreement 
between a series of measurements obtained from multiple sampling of the homogenous 
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sample under the prescribed conditions. A more comprehensive definition proposed by the 
ICH divides precision into three types 
1. Repeatability 
2. Intermediate Precision 
3. Reproducibility 
1. Repeatability  
It is the precision of a method under the same operating conditions over a short period 
of time. One aspect of this is instrumental precision. A second aspect is sometimes termed 
intra-assay precision and involves multiple measurements of the same sample by the same 
analyst under the same conditions. 
2. Intermediate precision 
It is the agreement of complete measurements when the same method is applied many 
times within the same laboratory. This can include full analysis on different days, instruments 
or analysts, but would involve multiple preparations of samples and standards. 
3. Reproducibility  
It examines the precision between laboratories and is often determined in 
collaborative studies or method transfer experiments. Precision often is expressed by the 
standard deviation or relative standard deviation of the data set. 
1.11.2.3. Range 
             The range of a method can be defined as the upper and lower concentrations for 
which the analytical method has adequate accuracy, precision and linearity. The range of 
concentrations examined will depend on the type of method and its use. 
1.11.2.4. Specificity 
 Specificity is the ability to assess unequivocally the analyte in the presence of 
components, which may be expected to be present. Assuring specificity is the first step in 
developing and validating a good method. If specificity is not assured, method accuracy, 
precision and linearity all are seriously compromised. Method specificity should be 
reassessed continually during validation and subsequent use of the method. 
 1.11.2.5. Linearity 
 The linearity of an analytical procedure is its ability to obtain test results, which are 
directly proportional to the concentration of analyte in the sample. Linearity can be assessed 
by performing single measurements at several analyte concentrations. A linearity correlation 
coefficient above 0.999 is acceptable for most methods, especially for major components in 
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assay methods. The range of an analytical procedure is the interval between the upper and 
lower concentration of analyte in the sample. 
1.11.2.6. Detection Limit 
Several approaches for determining the detection limit are possible, depending on 
whether the procedure is a non-instrumental or instrumental. Approaches other than those 
listed below may be acceptable. 
a) Based on Visual Evaluation 
           Visual evaluation may be used for non-instrumental methods but may also be used 
with instrumental methods. 
            The detection limit is determined by the analysis of samples with known 
concentrations of analyte and by establishing the minimum level at which the analyte can be 
reliably detected. 
 b) Based on Signal-to-Noise 
         This approach can only be applied to analytical procedures which exhibit baseline 
noise. Determination of the signal-to-noise ratio is performed by comparing measured signals 
from samples with known low concentrations of analyte with those of blank samples and 
establishing the minimum concentration at which the analyte can be reliably detected. A 
signal-to-noise ratio between 3 or 2:1 is generally considered acceptable for estimating the 
detection limit. 
c) Based on the Standard Deviation of the Response and the Slope 
The detection limit (LOD) may be expressed as 
LOD     =       3.3 / S 
Where,    =        the standard deviation of the response. 
  S  =        the slope of the calibration curve (of the analyte). 
 
 
 d) Based on the Standard Deviation of the Blank 
         Measurement of the magnitude of analytical background response is performed by 
analyzing an appropriate number of blank samples and calculating the standard deviation of 
these responses. 
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e) Based on the Calibration Curve 
           A specific calibration curve should be studied using samples containing an analyte in 
the range of DL. The residual standard deviation of a regression line or the standard deviation 
of y-intercepts of regression lines may be used as the standard deviation. 
 1.11.2.7. Quantitation Limit 
           Several approaches for determining the quantitation limit are possible; depending on 
either the procedure is a non-instrumental or instrumental. Approaches other than those listed 
below may be acceptable. 
a)  Based on Visual Evaluation 
          Visual evaluation may be used for non-instrumental methods but may also be used with 
instrumental methods. 
          The quantitation limit is generally determined by the analysis of samples with known 
concentrations of analyte and by establishing the minimum level at which the analyte can be 
quantified with acceptable accuracy and precision. 
 b) Based on Signal-to-Noise Approach 
         This approach can only be applied to analytical procedures that exhibit baseline noise. 
Determination of the signal-to-noise ratio is performed by comparing measured signals from 
samples with known low concentrations of analyte with those of blank samples and by 
establishing the minimum concentration at which the analyte can be reliably quantified.  A 
typical signal-to-noise ratio is 10:1. 
 
 
c) Based on the Standard Deviation of the Response and the Slope 
               Quantitation Limit (LOQ) may be expressed as 
                       LOQ   =     10 /S 
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 Where,                      =      the standard deviation of the response. 
           S         =       the slope of the calibration curve (of the analyte). 
d) Based on Standard Deviation of the Blank 
           Measurement of the magnitude of analytical background response is performed by 
analyzing an appropriate number of blank samples and calculating the standard deviation of 
these responses. 
e) Based on the Calibration Curve 
         A specific calibration curve should be studied using samples, containing an analyte in 
the range of QL. The residual standard deviation of a regression line or the standard deviation 
of y-intercepts of regression lines may be used as the standard deviation. 
1.11.2.8. Ruggedness 
            Method ruggedness is defined as the reproducibility of results when the method is 
performed under actual use conditions. This includes different analysts, laboratories, 
columns, instruments, sources of reagents, chemicals, solvents and so on. Method ruggedness 
may not be known when a method is first developed, but insight is obtained during 
subsequent use of that method. 
1.11.2.9. Robustness 
            The concept of robustness of an analytical procedure has been defined by the ICH as 
“a measure of its capacity to remain unaffected by small, but deliberate variations in method 
parameters”. The most important aspect of robustness is to develop methods that allow for 
expected variations in the separation parameters. 
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Table 3 
Acceptance criteria of validation for HPLC 
S.No Characteristics Acceptance Criteria 
1 Accuracy 
Recovery 98-102% with 80, 100, 120% 
spiked sample. 
2 Precision  
2a Repeatability RSD < 2% 
2b Intermediate precision RSD < 2% 
3 Specificity/ selectivity No interference 
4 Detection Limit S/N > 2 or 3 
5 Quantitation  Limit S/N > 10 
6 Linearity r > 0.999 
7 Range 80-120% 
8 Stability >24h or > 12h 
  
1.12. SYSTEM SUITABILITY PARAMETERS9 
           System suitability testing is an integral part of many analytical procedures. The tests 
are based on the concept that the equipment, electronics, analytical operations, and samples to 
be analyzed constitute an integral system that can be evaluated as such. System suitability test 
parameters to be established for a particular procedure depend on the type of procedure being 
validated.  
 The parameters that are affected by the changes in chromatographic conditions are, 
➢ Retention or Capacity factor (KA) 
➢ Resolution (Rs) 
➢ Selectivity () 
➢ Column efficiency (N) and 
➢ Peak asymmetry factor (As) 
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I.RETENTION OR CAPACITY FACTOR (KA) 
 
 The retention of a drug with a given packing material and eluent can be expressed as 
retention time or retention volume, but both of these are dependent on flow rate, column 
length and column diameter. The retention is best described as a column capacity ratio (K), 
which is independent of these factors. The column capacity ratio of a compound (A) is 
defined as  
0
0
0
0
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Where, 
VA = Elution volume of A 
V0 = Elution volume of a non retained compound (void volume) 
At constant flow rate, retention times (tA and to) can be used instead of retention volumes. 
Retention data is sometimes expressed, relative to a known internal standard (B). The ratio of 
retention times (tA/tB) can be used, but the ratio of adjusted retention times  



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better when data need to be transferred between different chromatographs. 
 The values of k’ of individual bands increase or decrease with changes in solvent 
strength. In reversed phase HPLC, solvent strength increases with the increase in the volume 
of organic phase in the water/organic mobile phase. Typically an increase in percentage of 
the organic phase by 10 % by volume will decrease k’ of the bands by a factor of 2-3. 
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II.Resolution (Rs) 
 
 
            The resolution, Rs of two neighboring peaks is defined by the ratio of the distance 
between the two peak maxima. It is the difference between the retention times of two peak 
maxima. It is the difference between the retention times of two solutes divided by their 
average peak width. For baseline separation, the ideal value of Rs is 2.0. It is calculated by 
using the formula, 
 
)(5.0 21
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  
Where,  
Rt1 and Rt2 are the retention times of components 1 and 2.  
W1 and W2 are peak widths of components 1 and 2. 
III.Selectivity ()            
 
 The selectivity (or separation factor) , is a measure of relative retention of two 
components in a mixture. The ideal value of selectivity is 2. It can be calculated by using the 
formula,  
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 Where, V0 is the void volume of the column and V2 and V1 are the retention    
volumes of the second and the first peaks respectively. 
IV.Column efficiency                 
 Efficiency N of a column is measured by the number of theoretical plates per meter. It 
is a measure of band spreading of a peak. Smaller the band spread, higher is the number of 
theoretical plates, indicating good column and system performance. 
 
 Columns with N ranging from 5,000 to 100,000 plates/meter are ideal for a good 
system. Efficiency is calculated by using the formula, 
2
2
16
W
Rt
N   
Where, Rt is the retention time and W is the peak width. 
V.Peak asymmetry factor (As) 
 
 Peak asymmetry factor As can be used as a criterion of column performance. The peak 
half width b of a peak at 10 % of the peak height divided by the corresponding front half 
width a gives the asymmetry factor. 
a
b
A
s
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1.13. STATISTICAL PARAMETERS10 
i) Regression equation 
The linear relationship is characterized by at tendency of the points of the scattered 
diagram to cluster along a straight line known as the regression line. 
                                        Y=a + bX 
 It is used to describe the dependence of one characteristic (Y) up on the other 
characteristic (X), both X,Y represent values of two characters a,b  are two constants it will 
be evident that two regression lines can be computed for every set of data-one each to 
describe the dependence of one character to another. b is known as regressive coefficients 
which shows change expected in Y for unit change in X, it is dependence of Y & X; b is the 
regressive coefficient of Y& X. The regressive coefficient of b is estimated,  
 
b =   the slope of the regression line and is calculated by this formula 
x = an arbitrarily chosen value of the predictor variable for which the corresponding value of 
the criterion variable is desired. 
ii) Correlation coefficient 
A measure of the strength of the relationship between two variables is provided by the 
coefficient of correlation denoted by r, if the relationship between the two variables is of the 
linear form. It is also called the coefficient of linear correlation. 
iii) Pearson’s correlation 
The correlation coefficient calculation for data values should be +1 or -1 where the 
values of         
 Correlation coefficient is +1 – positive 
 Correlation coefficient is -1 – negative. 
 
Where, X – value of one character 
            Y – Value of another character 
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iv) Standard Deviation  
 It is the square root of the average of the squared deviations of the observations. From 
the arithmetic mean, it is used for measures of dispersion. It is denoted by     
    
Standard Déviation =  
1
)( 2


n
xx
 
R.S.D (%) = 100
x
S.D
  
Where  = Sum of observations 
x = Mean or arithmetic average (x / n) 
x = Individual observed value 
x – x = Deviation of a value from the mean 
n = Number of observations 
v) Standard error of mean (S.E) 
 The population of standard deviation is not given, but the size of s is large. So the 
sample standard deviation is representing the population of standard deviation. 
S.E. = 
n
S.D
  
Where,   S.D = Standard Deviation 
                   n = No. of observations 
1.14. STABILITY INDICATING METHOD11 
           A stability indicating method is a validated qualitative analytical procedure that can 
detect the cha nges with time in the properties of drug substance and drug product under 
defined storage conditions. A stability indicating assay method accurately measures the active 
ingredient without interference from other peaks and is sensitive enough to detect and qualify 
the degradation products/impurities. To develop a stability indicating method, stress testing in 
the form of forced degradation should be carried out at an early stage so that impurities and 
degradation products can be identified and characterized. 
            The stability-indicating assay is a method that is employed for the analysis of stability 
samples in pharmaceutical industry. With the advent of International Conference on 
Harmonization (ICH) guidelines, the requirement of establishment of Stability-Indicating 
Assay Method (SIAM) has become more clearly mandated. The guidelines explicitly require 
conduct of forced decomposition studies under a variety of conditions, like pH, light, 
oxidation, dry heat, etc. and separation of drug from degradation products.  
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              Elaborate definitions of stability-indicating methodology are, however, provided 
in the United States-Food and Drug Administration (US-FDA) stability guideline of 1987 [5] 
and the draft guideline of 1998 [6].  
              Stability-indicating methods according to 1987 guideline were defined as the 
‘quantitative analytical methods that are based on the characteristic structural, chemical or 
biological properties of each active ingredient of a drug product and that will distinguish each 
active ingredient from its degradation products so that the active ingredient content can be 
accurately measured.’ 
             This definition in the draft guideline of 1998 reads as: ‘validated quantitative 
analytical methods that can detect the changes with time in the chemical, physical, or 
microbiological properties of the drug substance and drug product, and that are specific so 
that the contents of active ingredient, degradation products, and other components of interest 
can be accurately measured without interference.’ 
            According to FDA guidance document, a stability-indicating method is “a validated 
quantitative analytical procedure that can detect the changes with time in the pertinent 
properties of the drug substance and drug product. A stability indicating method accurately 
measures the active ingredients, without interference from degradation products, process 
impurities, excipients, or other potential impurities.”               
HPLC has been very widely employed in stability studies due to its high-resolution capacity, 
sensitivity and specificity. Non-volatile, thermally unstable or polar/ionic compounds can 
also be analyzed by this technique. Therefore, most of the SIAMs have been established 
using HPLC. 
1.14.1. Steps in the Development of Validated SIAMS 
The practical steps involved in the development of SIAMs are discussed below: 
Step I   :    Critical study of the drug structure to assess the likely decomposition route(s) 
Step II   :    Collection of information on physicochemical properties 
Step III :    Stress (forced decomposition) studies 
Step IV :    Preliminary separation studies on stressed samples 
Step V  :    Final method development and optimization 
Step VI: Identification and characterization of degradation products, and preparation of 
standards 
Step VII:  Validation of SIAMs 
             ICH guideline Q1AR and the ICH’s Common Technical Document [181] suggest the 
drug substance only subjected to stress conditions for the development of a SIAM. 
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1.14.2. Forced Degradation Studies 
              Forced degradation or stress testing is undertaken to demonstrate specificity when 
developing stability-indicating methods. These studies also provide information about the 
degradation pathways and degradation products that could form during storage. Forced 
degradation studies may help facilitate pharmaceutical development as well in areas such as 
formulation development, manufacturing, and packaging, in which knowledge of chemical 
behavior can be used to improve a drug product. 
           Forced degradation studies (or stress testing) are discussed and differentiated from 
accelerated testing, which is done during formal stability testing, in ICH Q1A (R2) [1]. The 
guidance states, 
           “Stress testing of the drug substance can help identify the likely degradation products, 
which can in turn help establish the degradation pathways and the intrinsic stability-
indicating power of the analytical procedures used. The nature of the stress testing will 
depend on the individual drug substance and the type of drug product involved.” 
          As stated in ICH Q1A, forced degradation studies can be used as a predictive tool [3]. 
The initial purpose of these studies is to investigate stability-related properties of an API and 
understand the degradation products and pathways of the compound. They are also used to 
provide samples for the development of stability-indicating analytical methods for the API. 
The information gleaned from a forced degradation investigation can also be utilized in 
several other areas of development, including analytical development (methods 
development), formulation development (formulation choice and storage conditions), 
manufacturing/processing parameters (synthesis/salt selection of API and manufacture of 
formulations), safety/toxicological concerns (possible genotoxic degradation products), 
metabolism (identification of possible metabolites) and discovery (design of better or more 
stable APIs). 
1.14.3 Forced degradation studies are carried out for the following reasons: 
1. Development and validation of stability-indicating methodology 
2. Determination of degradation pathways of drug substances and drug products 
3. Discernment of degradation products in formulations that  are related to drug 
substances versus those that are related to non–drug substances (e.g., 
excipients) 
4. Structure elucidation of degradation products 
5. Determination of the intrinsic stability of a drug substance molecule. 
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1.14.4. Degradation Studies of a Drug Substance 
     For degradation studies of a drug substance, FDA requests the following at the time of        
registration: 
• Stressing the drug substance in solution or suspension at acidic and alkaline 
pH and  under oxidation conditions  
• Stressing the solid bulk drug substance at temperature and temperature - 
humidity     conditions in excess of accelerated conditions  
• Stressing the drug substance photolytically in the solid state and/or in solution  
 
 
 
There are a number of common stresses which are used to 
▪ pH (acid/base) 
Chemical processes are often catalyzed by the presence of acids and bases. The exposure of 
materials to these can therefore accelerate degradation reactions. 
▪ Temperature 
         In accordance to Arrhenius kinetics, increasing temperature increases the rate of any 
degradation process. Temperature is often used in conjunction with other stresses to increase 
reaction rates. 
➢ Oxidation 
➢ Concentration 
➢ Light 
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          For the stress conditions to provide the best compromise between overstressing and 
understressing the sample, the desired target for the extent of observed degradation is 
approximately 5-20%. Overstressing the sample may lead to further degradation of the 
primary degradants or it may generate irrelevant degradants that would never be seen in 
formal stability studies. At the other extreme, understressing may fail to generate important 
degradation products that may be generated in formal stability studies. The desired extent of 
degradation can be achieved by varying one or more of the stress conditions, e.g., exposure 
time, temperature, or concentration of stressing agent (acid, base, oxidizer, etc.).12. 
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2. DRUG PROFILE 
2.1 SALBUTAMOL SULFATE21 
Molecular structure     : 
                                                  
Chemical Name : (RS)- 4-[2-(tert- Butylamino)-1-hydroxyethyl)-2                                                                                        
(hydroxymethyl) Phenol 
Molecular Formula  : (C13H21NO3)2.H2SO4  
Molecular weight  : 576.7 g/mol  
Therapeutic class  : Selective beta2-adrenergic receptor agonist 
Category   :  Bronchodilators, Sympathomimetic, Chronic obstructive,                                    
                                                   Pulmonary disease 
Metabolism   : Liver 
Onset of action  :  <15 min (inhaled), <30 min (pill) 
Duration of action  : 2-6 hrs 
Excretion   : Kidney 
Description   : A white or almost white, crystalline powder 
Solubility :  Soluble in ethanol, sparingly soluble in water, very soluble in 
chloroform 
Melting point   : 1470-1490C 
Half life   : 3.8-6 hours 
Loss on drying  : Not  more than 0.5% 
Assay    : 99.99% w/w 
Storage   : Store protected from light 
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Mechanism of action13       :  Salbutamol is a beta(2)-adrenergic agonist and thus it stimulateous 
Beta(2)-adrenergic receptors. Binding of albuterol to beta(2) 
receptors in the lungs results in relaxation of bronchial smooth 
muscles. It is believed that salbutamol increases cAMP. 
Production by activating adenylate cyclase, and the actions of 
salbutamol are mediated by cAMP. Increased intercellular 
cyclic AMP increases the activity of  cAMP-dependent protein 
kinase A, which inhibits the phosphorylation of myosin and 
lowers intracellular calcium concentration .A lowered  
intercellular calcium concentration leads to a smooth muscle 
relaxation and bronchodilation.In addition to bronchodilation, 
salbutamol inhibits the  release of broncho-constricting agents 
from mast cells, inhibits microvascular  leakage, and enhances 
mucocilliary clearance. 
                                                 
Adverse  effect14                    : Palpitation, Tachycardia, Chest discomfort, Headache, Tremor,      
Anxiety 
Contraindication            : Contraindicated in person with a history of,   
                                                  1). Hypersentivity reaction  
                                                  2). Urticaria 
                                                   3). Angioedma  
                                                   4). Tachyarrthymias 
Marketed Formulation : 1). Tablet  
                                                  2). Syrup 
                                                  3). Inhaler  
                                                  4). Nebulizer and  
                                                  5). Intramuscular or Intravenous Injectable form                                                                                                                                                                                                                                      
Brand name                    : 1). Accuneb  
                                                 2). Proventil  
                                                  3). Ventolin 
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2.2 GUAIFENESIN21 
Molecular structure   :  
                                                                                                                                                                         
Chemical name  : 3-(2-methoxyphenoxy) propane-1,2-diol 
Molecular formula  : C10H14O4 
Molecular weight  : 198.2g/mol 
Therapeutic category : 1). Expectorant 
                                                  2). Muscle relaxing action                      
Description   : White or almost white, crystalline powder 
Solubility   : Free soluble in ethanol, soluble chloroform, glycerol, water  
Melting point   : 78.5- 79°C 
Half life   : 1 hour 
Absorption   : Rapidly absorbed from GI tract 
Metabolism   : Rapidly hydrolysed (60% within 7 hours) 
Excretion   : Excreted in Urine  
Loss on drying  : Not more than 0.5%   
Storage                                   : Stored in tight containers at room temperature between 15°C and   
30°C 
Mechanism of action15         :    Guaifenesin may act as an irritant to gastric vagal receptor,  And 
recruit efferent parasympathetic reflexes that causes Glandular 
exocytosis of a less viscous mucus mixture . Cough may be 
provoked. This combination may flush tenacious ,congealed 
mucopurulent material from obstructed small  airways and lead 
to temporary improvement dyspnea or work of breathing. 
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Adverse effect16  : 1). Dizziness 
                                                  2). Headache  
                                                  3). Nausea  
                                                  4). Vomiting 
                                                  5). Skin rash 
                                                  6). Stomach pain 
                                                  7). Urticaria (hives).      
Contraindication  : Contraindicated in patients hypersentivity to the drug  
Marketed formulation : 1). Capsules 
                                                  2). Tablets 
                                                  3). Syrup  
Brand name17  :1). Mucinex 
                                                 2). Fenesin IR 
                                                 3). Robitussin 
2.3 AMBROXOL HYDROCHLORIDE21 
Molecular structure                                  :        
                                                           . HCL 
Chemical name  : Trans-4-[(2-amino-3,5- 
dibromobenzyl)amino]cyclohexanol Hydrochloride 
Molecular formula   : C13H19Br2ClN2O 
Molecular weight   : 414.566 g/mol 
Therapeutical category18  : Mucolytic agent, Expectorant                                          
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Description    : A white or yellowish crystalline powder 
Solubility                                            :  Sparingly soluble in water , soluble in methanol 
                                                                Practically Insoluble in methylene chloride     
Melting point    : 233-234.5°C 
Half life    : 7-12 hours 
Loss on drying   : Not more than  0.5% 
Protein binding   : Approximately 90% 
Storage                                               :  Store protected from light, temperature not exceeding    
30°C 
Mechanism of action19                     : Ambroxol is a mucolytic agent. Excessive nitric oxide 
(NO) is Associated with inflammatory and some other 
disturbances of Airway functions. NO enhances the 
activation of soluble Guanylate cyclase and cGMP 
accumulation. Ambroxol has been shown to inhibit the 
NO-dependent activation of soluble Guanylate cyclase.It is 
also possible that the inhibition of NO-dependent 
activation of soluble guanylate cyclase can suppress the 
excessive mucus secretion, therefore it lowers the phlegm 
viscosity and improves the mucocilliary transport of 
bronchial secretions.  
Adverse effect20   : 1). Occasional gastrointestinal side effect 
                                                         2). Allergic reaction 
                                                         3). Heart Burn 
                                                         4). Dry mouth 
                                                         5). Dyspepsia  
                                                         6). Nausea  
                                                         7). Vomiting 
                                                          Very rarely,  
                                                         i). Stevens-Johnson syndrome 
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Contraindication                          : Hypersentivity to the drug, Hereditary disorders of 
Carbohydrates tolerance (product contain lactose) 
Duodenal ulcer, convulsion. There is no absolute 
Contraindication but in patient with gastric ulceration 
relative caution should be observed. 
                                                                                                                                                                                     
Marketed formulation         : 1). Tablet 
                                                        2). Syrup 
Brand name           : 1). Acticol  
                                                       2). Acolyt 
                                                       3). Acocontin 
                                                       4). Ambrodil 
 
 
 
Chapter 3                                                                                                         Literature Review 
 
Nandha college of Pharmacy & Research Institute 37 
 
3.  LITERATURE  REVIEW 
Literature review was carried out to enumerate the reported analytical methods for the 
selected drugs individually or in combination with other drugs. 
Neelima  et al.,22 have developed  the different analytical methods available for detection of 
Guaifenesin alone and in combination from various pharmaceutical formulations. They are 
many analytical techniques have been reported for simultaneous estimation of Guaifenesin and 
its combined pharmaceutical dosage form but only fewer methods have been reported for 
estimation of Guaifenesin alone. Chromatographic separation was performed on symmetry 
(C18) inertsil ODS 3V (4.6mm×150mm,4.5μm) column, with mobile phase comparising of 
mixture of phosphate buffer (pH 6.0,adjusted with NaOH) and acetonitrile in the ratio of  
40:60%v/v, at the flow rate 1ml/min at detection wavelength of  220nm. Some of those 
techniques are UV spectrophotometry, high performance liquid chromatography (HPLC), high-
performance thin layer chromatography (HPTLC), liquid chromatography - mass spectrometry 
(LC-MS), gas chromatography (GC),and ultraperformance liquid chromatography (UPLC). 
Amongst, various analytical methods are available for the quantification of single and 
multicomponent dosage forms. 
Bhauvaneswara et al.,23 have developed  the present study a validated stability indicating RP 
HPLC method for quantification of GFS, LCZ and ABX was established. Compared with the 
reported methods, this method represents the first report about a stability indicating method for 
the determination of GFS, LCZ and ABX. With the proposed method a satisfactory separation 
of three drugs from the degradation products and impurities, extended linear range and rapid 
analysis time were carried out. C18 column (250×4.6 mm, 5 μm Particle Size) with the mobile 
phase consisting of 0.01 M Phosphate Buffer pH-4.5 adjusted with 1% of Ortho Phosphoric 
Acid: Acetonitrile (45:55% v/v). Detection was carried out at 254 nm. A high recovery of GFS, 
LCZ and ABX in formulation was achieved. The proposed method ensured a precise and 
accurate determination of GFS, LCZ and ABX in formulation. No interference from the 
excipients was noticed. 
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Ankit B. Chaudhary et al.,24 have developed a Reverse Phase High Performance Liquid 
Chromatographic method was developed for the simultaneous estimation of Bromhexine 
Hydrochloride, Guaiphenesin and Chlorpheniramine Maleate. The separation was achieved by 
C18 column (250×4.6 mm, 5 μm Particle Size) with the mobile phase consisting of 0.01 M 
Potassium dihydrogen Phosphate Buffer pH-3 adjusted with 1% of Ortho Phosphoric Acid: 
Acetonitrile (40:60% v/v). Detection was carried out at 254 nm. RP-HPLC method gives 
retention time of Bromhexine Hydrochloride (BH), Guaiphenesin (GP) and Chlorpheniramine 
Maleate (CPM) was found to be 5.54min, 2.03min and 6.61 min respectively. The method has 
been validated for ICH Guideline. Linearity for Bromhexine Hydrochloride, Guaiphenesin and 
Chlorpheniramine Maleate were found in the range of 10-60 μg/ml, 125-750μg/ml and 5-30 
μg/ml. The percentage recoveries obtained for BH, GP and CPM were found to be in range of 
99.40-101.95%, 100.63-101.51% and 100.64-101.51% respectively in tablet. Limit of detection 
and Limit of quantification was  found to be 1.449μg/ml and 4.830μg/ml for BH, 15.02μg/ml 
and 50.08μg/ml for GP and 0.795μg/ml and 2.651μg/ml for CPM respectively. 
 
Hina Bagada et al.,25 have developed the study is to develop simple, precise, accurate, rapid 
and sensitive Method of Reverse Phase High Performance Liquid Chromatography (RP-HPLC) 
and High Performance Thin Layer Chromatography (HPTLC) for simultaneous estimation of 
Ambroxol HCl (AMB), Dextromethorphan HBr (DEX) and Guaifenesin (GUA) in 
Pharmaceutical Cough Cold Preparation and statistical comparison of both method was done. 
For RP-HPLC method Hibar RP-C18 (250mm × 4.6mm i.d. with particle size of 5μm) 
analytical column was used. The mobile phase composition used for RP-HPLC method was 
Acetonitrile - Methanol - 10mM Phosphate Buffer – 0.3% Triethyl Amine (25:15:60 v/v) and 
pH was adjusted to 3 using Orthophosphoric Acid. Flowrate was kept 1 mL/min. Detection was 
done at 205 nm using PDA detector. Linearity range for RP-HPLC method was found to be 3- 
10.5 μg/ml, 2-7 μg/ml and 10-35 μg/ml for AMB, DEX and GUA respectively. In HPTLC 
method Merck HPTLC plates precoated with 60F254 silica gel on aluminium plates were used 
as stationary phase. Mobile phase used in HPTLC method was Toluene – Methanol – 
Chloroform – Glacial Acetic Acid (6.5:1.5:1.5:0.5 v/v/v/v). Detection was done using Camag 
TLC scanner at 275 nm. Linearity range was found to be 1.5-3 μg/band, 1-2 μg/band and 5-10 
μg/band for AMB, DEX and GUA respectively for HPTLC method.Statistical comparison of 
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RP-HPLC and HPTLC was done by application of t-Test to recovery data of both methods. 
Finally concluded that A novel RP-HPLC and HPTLC methods were developed for 
simultaneous estimation of AMB, DEX and GUA in syrup dosage form. Both the method gives 
the good resolution for all three drugs. The developed method was validated and found to be 
sensitive, accurate, specific and reliable for simultaneous estimation of AMB,DEX and GUA in 
syrup dosage form. The proposed method can be used effectively in routine analysis. 
  
T. Manjula et al.,26 have developed for simultaneous estimation of  Levofloxacin hemihydrates 
(LEVH) and Ambroxol HCL (AMXL HCL) in pharmaceutical dosage form. Chromatographic 
separation was performed on symmetry (C18) inertsil ODS 3V (4.6mm×150mm,4.5μm) 
column,with mobile phase comparising of mixture of phosphate buffer (pH 6.0,adjusted with 
NaOH) and acetonitrile in the ratio of  35:65%v/v, at the flow rate 1ml/min at detection 
wavelength of  231nm.The retention times of LEVH and AMXL HCL were found to be and 
2.464 mins respectively with a run time of 6 mins, with a resolution of 6.61.As per ICH 
guidelines the method was validated for linearity,accuracy,precision,limit of detection and limit  
of quantification,and ruggedness,robustness.Linearity of LEHV was found in the range of 20- 
60μg/ml and that for AMXL HCL was found to be 37.5-112.5μg/ml.The correlation coefficient 
for LEVH and AMXL HCL were 0.997 and 0.995 respectively.The LOD values for LEVH and 
AMXL HCL were 2.66μg/ml,0.88μg/ml and respectively .The LOQ values for LEVH and 
AMXL HCL were 8.06 and 0.29μg/ml respectively.This demonstrates that the developed 
method is simple,precise,rapid,selective,accurate and reproducible for simultaneous estimation 
of LEVH and AMXL HCL combined dosage form. 
A. Porel et al.,27 have developed the present study was the development and subsequent 
validation of a simple, precise and stability-indicating reversed phase HPLC method for the 
simultaneous determination of guaifensin, terbutaline sulphate and bromhexine hydrochloride in 
the presence of their potential impurities in a single run. The photolytic as well as hydrolytic 
impurities were detected as 3,5-dihydroxybenzoic acid, 3,5-dihydroxybenzaldehyde, 1-(3,5 
dihydroxyphenyl)-2-[(1,1-dimethylethyl) amino]-ethanone from terbutaline, 2-methoxyphenol 
and an unknown impurity identified as(2RS)-3-(2-hydroxyphenoxy)-propane-1,2-diol from 
guaifenesin. The chromatographic separation of all the threeactive components and their 
impurities was achieved on Wakosil II column, using phosphate buffer (pH 3.0) and acetonitrile 
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as mobile phase which was delivered initially in the ratio of 80:20 (v/v) for 18 min, then 
changed to 60:40 (v/v) for next 12 min, and finally equilibrated back to 80:20 (v/v) for 10 min. 
Other HPLC parameters were flow rate at 1.0 ml/min, detection wavelengths 248 and 280 nm, 
injection volume 10 ml. The calibration graphs plotted with five concentrations of each 
component were linear with a regression coefficient R2 >0.9999. The limit of detection and 
limit of quantitation were estimated for all the five impurities. The established method was then 
validated for linearity, precision, accuracy, and specificity and demonstrated to be applicable to 
the determination of the active ingredients in commercial and model cough syrup. No 
interference from the formulation excipients was observed. These results suggest that this LC 
method can be used for the determination of multiple active ingredients and their impurities in a 
cough and cold syrup. 
 
Varaprasad Bobbarala et al.,28 have developed a novel and single RP-HPLC method was 
developed for the determination of ten active ingredients (Codeine phosphate, Paracetamol,  
Chloropheniramine Maleate, Theophylline,Pseudoepidrine HCl, Ambroxol, Salbutamol, 
Guaiphenesin, Dextromethorphan and Diphenhydramine HCl) in all pharmaceutical dosage 
forms, along with preservative (Sodiumbenzoate) and validated the method as per ICH and 
FDA guidelines. The separation was achieved on a X-Terra C18, 15cm x 4.6mm, 3.5 2 in the 
simple gradient mode using Sol-A:buffer and Sol-B: Acetonitrile (0-5min, sol-A:97-97; 5-
10min- sol-A:97-92; 10-15min- sol-A:92-68; 15-23min- sol-A:68-68; 23-25min- sol-A:68-97 
and 25-30min- sol-A:97-97) with 0.8 mL per min flow rate. Column oven temperature 
maintained at 40°C and performed the analysis with 220 nm. Quantification was achieved with 
402g per mL for all ingredients with 100 ±3.0% recovery. The method was validated by 
determining its sensitivity, linearity, accuracy and precision. The proposed method is single, 
shorter runtime, accurate and reproducible. This method can be applied for routine analysis of 
all ten active ingredients quantification in all pharmaceutical dosage forms. 
  
Sandhya N Kumar et al.,29 have developed Salbutamol Sulphate and bromhexine 
hydrochloride as components of a multi-ingredient formulation is useful in asthma therapy. This 
article reviews the Chromatographic methods for simultaneous determination of bromhexine 
and salbutamol in pharmaceutical samples. The most commonly adopted methods for the 
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determination of bromhexine and salbutamol are RP- HPLC. Hibar RP-C18 (250mm × 4.6mm, 
5μm) column was used for separation, flow rate 1.2mL/min and wavelength was 220nm.  
Recent preferences in the simultaneous estimation of bromhexine and salbutamol proves 
primacy of RP- HPLC and confirms a general trend of moving towards more sensitive methods 
having higher resolution potential, consuming small quantities of samples and reagents and 
requiring less time for analysis. 
 
Senthil raja M And GiriRaj P et al.,30 have developed a simple, accurate and precise reversed 
phase HPLC method for rapid and simultaneous quantification of Terbutaline Sulphate, 
Bromhexine Hcl and Guaifenesin in a cough syrup formulation. Separations were carried out on 
a phenomenex Luna C18 column (250 X4.6 mm ID), 5 μm particle size. A isocratic elution 
system was developed using acetonitrile‐methoanol‐buffer (350:450:250 v/v). The elution of the 
analytes was achieved in less than 15 min with a flow rate of 1.2 ml/min. Detection was by UV 
absorbance at a wavelength of 220 nm. Quantification of the components in actual syrup 
formulations was calculated against the responses of freshly prepared external standard 
solutions. Different analytical performance parameters such as linearity, precision, accuracy, 
limit of detection, limit of quantification, and robustness were determined according to 
international conference on harmonization ICH Q2B guidelines. All the parameters of 
validation were found in the acceptance range of ICH guideline. 
 
Raval Kashyap et al.,31 have developed and validate a simple& accurate Spectrophotometry 
methods for simultaneous estimation of Ketotifen and Salbutamol in their combined 
pharmaceutical dosage form. Two simple, accurate, precise U.V Spectroscopy methods have 
been developed. First method was based on Simultaneous Equation method. Here 301 nm was 
selected for the estimation of Ketotifen& 276 nm selected for estimation of Salbutamol. The 
second method was Dual wavelength method, Here 284 nm & 267.84 nm selected for the 
estimation of Ketotifen where Salbutamol show same absorbance. Other 315 nm & 284.59 nm 
selected for estimation of Salbutamol where Ketotifen show same absorbance. Ketotifen and 
Salbutamol showed linearity in the range of 5-25μg/ml and 10- 50μg/ml respectively in both 
methods. Both methods were validated by validation parameters and it show result where lie 
within its acceptance criteria as per ICH Q2 (R1) guideline. Hence, it can be successfully used 
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for the routine analysis of Ketotifen and Salbutamolin their combined pharmaceutical dosage 
forms. 
 
Rajan V. Rele et al.,32 have developed A simple, rapid and accurate high performance liquid 
chromatography method is described for simultaneous determination of guaiphenesin and 
salbutamol sulphate from active pharmaceutical ingredients. The separation of drug was 
achieved on Zorbax Eclipse C18 (250 x 4.6 mm i.d.) with 5 μ particle size column showed most 
favorable chromatographic pattern over the other columns. The mobile phase consisted of a 
mixture of buffer of pH 4.3 and acetonitrile [75:25 % (v/v)]. The detection was carried out at 
wavelength 225 nm. The mixture of buffer of pH 4.3 and acetonitrile [75:25% (v/v)] was used 
as a diluent. The method was validated for system suitability, linearity,accuracy, precision, 
robustness, stability of sample solution. The method has been successfully used to analyze 
guaiphenesin and salbutamol sulphate from combined dosage form. 
 
M. Abdelkawy et al.,33 have developed the simultaneous determination of a mixture of 
Ambroxol HCl (A) and Guaifenesin (G) in presence of the oxidative degradate (AD) of A and 
guaicol (GD), the impurity of G . The first method is an isocratic HPLC method, where 
separation of the four components A, AD, G and GD was achieved on C18 column using water: 
methanol (80: 20, v/v, containing 1% triethylamine, pH 2.9) with a flow rate of 1.5 ml/min and 
UV detection at 220nm. A linear relationship in the range of 5-80 μg.ml-1 and 10-150 μg.ml-1 
was obtained for A and G, respectively. The second method was a TLC-spectrodensitometric 
method, where the drugs together with AD and GD were applied on silica gel 60F254 plates and 
a mobile phase consisted of chloroform: methanol: ethyl acetate:acetic acid (70: 8: 12:10, by 
volume) was used for separation. Densitometric evaluation of the separated zones was 
performed at 270 nm. The regression analysis for the calibration plots showed good correlation 
over the range 1-7 μg/band and 2-10 μg/band for A and G, respectively. The third method was a 
multivariate spectrophotometric calibration method where principal component regression 
(PCR) and partial least squares (PLS) methods were used for the determination of the four 
components A, AD, G, and GD. The three methods were applied to pharmaceutical dosage 
forms containing either ambroxol alone (drops, capsules and tablets) or A together with G 
(syrup). Model update of multivariate calibration was used to determine A and G in syrup 
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dosage form due to interfering additives. Results for the three methods were statistically 
compared with those obtained by applying reference reported methods for the drugs and showed 
that the proposed methods are accurate, precise, and can be easily applied.  
 
Nidhi dubey et al.,34 have developed Simultaneous Determination of  Ambroxol, Guaifenesin 
and Salbutamol in single dosage form .The method has been validated as per the guidelines of 
ICH and FDA .The finalized Reverse Phase-HPLC method is revealed with significant shorter 
retention time of 15 min with simple isocratic program .The separation is achieved  on C- 
8,5μm;250mm× 4.6mm column with flow rate 1.0 ml, per minute in isocratic mode using 
disodium hydrogen ortho – phosphate buffer (4.5) and methanol as mobile phase column oven 
temperature is maintained at 25°C and observations are recorded at 220nm. The method is 
simple, accurate, reproducible and short and can be used for simultaneous analysis of ambroxol, 
guaifenesin and salbutamol in several single dose form formulation available in the market. 
 
Paul M. Njaria et al.,35 have developed for the Simultaneous Determination of Bromhexine, 
Guaifenesin, Ambroxol, Salbutamol/Terbutaline, Pseudoephedrine, Triprolidine and 
Chlorpheniramine maleate in cough –cold syrups commonly marketed in Kenya. Separation 
was achieved using a Gemini NX C18 column (250× 4.6mm,5μm) maintained at 40°C and a 
mobile phase consisting of acetonitrile  -0.25 M ammonium acetate  and pH 3.0-water 
(35:4:10:51,%v/v/v/v) delivered  at 1.0 ml min-1.The eluents were monitored by means of UV 
detection at 254nm .During validation ,the method satisfied the Inetrnational  Committee On 
Hormonisation acceptance createria for linearity,sensitivity,precision,accuracy and 
robustness.The development liquid chromatographic method was applied in the analysis of nine 
commercial samples obtained from Nairobi city country,Kenya.Extraction procedure were not 
applied during the assay of the samples,the significantly shorting the analysis the time. 
 
Srinivas Sumanth Kamatham et al.,36 have developed  method for simultaneous estimation of 
salbutamol (SAL), guaifenisin (GUA) and ambroxol (AMB) by high performance liquid 
chromatography (HPLC) in formulation was developed. The analysis was performed with a 
mobile phase containing acetonitrile (ACN) and potassium di-hydrogen phosphate (PDHP) 
adjusted to a pH- 4 in the ratio of 70 : 30 (% v/v) at a flow rate of 1.0 ml/min. A SHISEIDO 
C18 column (250 x 4.6mm i.d; 5μm) was used. A UV spectrum of salbutamol, guaifenisin and 
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ambroxol was recorded by scanning between 200-400 nm, from the overlapping spectra a 
wavelength of 215 nm is selected and simultaneous estimation is carried out. The analysis was 
performed in the linearity range of 2-16 μg/ml for Salbutamol, 0.5-4 μg/ml for Ambroxol and 5- 
40 μg/ml for Guaifenisin respectively. The correlation coefficient was 0.996 (SAL), 0.994 
(AMB), 0.998 (GUA). Thus the developed and validated chromatographic method for 
Salbutamol, Ambroxol and Guaifenisin is said to be rapid, precise (RSD<=2%), simple, 
accurate (% recovery=90-101%). 
 
Nirav C. Patel et al.,37 have developed a method for estimation of Ambroxol HCl, Guaifenesin 
and Levosalbutamol sulphate in syrup form. The study was done by combining three 
spectrophotometric methods viz use of first order derivative and colorimetry. The separation of 
Analytes was achieved within 10 min, employing a mixture of 10Mm triethylamine-phosphoric 
acid buffer (pH 3.0) and MeOH (60:40,%v/v) as isocratic mobile phase , pumped at 1.0ml min 
throgh a cyano column(5lm partical size). The analytes were detected at 215nm.  Absorption of 
Guaifenesin and Levosalbutamol sulphate were found to be zero at 323 nm, thus enabling the 
measurement of Ambroxol HCl, using specific absorbance in first order spectrum. Same way 
absorption of Ambroxol HCl and Levosalbutamol sulphate were found to be zero at 276 nm, 
thus enabling the measurement of Guaifenesin using specific absorbance in first order spectrum. 
For colorimetric measurement of Levosalbutamol Sulphate, a colored substance was obtained 
by coupling the oxidized product of Levosalbutamol sulphate with 4-aminoantipyrine and 
Potassium ferricyanide and its absorption was measured at 503 nm. The proposed method was 
statistically validated in accordance with ICH guidelines and results were found to be 
satisfactory for accuracy, precision and specificity. 
 
Levon A.Melikyan et al.,38 have developed and validated for quantitative determination of 
Guaifenesin impurities including 2-(2- methoxyphenoxy)propane-1,3-diol(β-isomer) and 2- 
methoxyphenoxy (guaicol) in different multi drug components pharmaceutical dosage 
forms,containing guaifenesin, ambroxol hydrochloride and salbutamol sulfate.The different 
analytical performance parameters such as linearity, precision, accuracy, limit of detection 
(LOD), limit of quantification (LOQ) were determined according to International Conference on 
Hormonization(ICH) Q2B guidelines.The chromatographic separation was achieved on EC 
NUCLEODUR-100-3C18(250 ×4.6mm,5μm packing) column using gradient elution of solvent 
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A (0.1M ammonium acetate buffer of  pH 6.8) and solvent B (acetonitrile : methanol (80:20)). 
The Ultra Violet Spectrophotometric determination was performed at 275nm.The linearity of 
the calibration curves for the analytes in the desired concentration range is good (r2=0.999) by 
High Performance Liquid Chromatography.The LOQ were 1 and 0.1μg/ml respectively for 
guaifenesin β-isomer and guaiacol.The percentage recovery of guaifenesin impurities was found 
to be within 98.6-101.2% of range.The developed method can be successfully used for 
identification and quantification  of guaifenesin impurities β-isomer and guaiacol in the 
presence of guaifenesin ,ambroxol hydrochloride and salbutamol sulfate in multi drug 
components  pharmaceutical formulations. 
  
Silvana E. Vignaduzzo et al.,39 have developed and validated for the Simultaneous 
determination of bromhexine, chlorpheniramine, paracetamol, and pseudoephedrine in common 
cold medications (tablets and syrups).The separation of Analytes was achieved within 10 min, 
employing a mixture of 10Mm triethylamine-phosphoric acid buffer (pH 4.0) and MeOH 
(35:65,v=v) as isocratic mobile phase , pumped at 1.0ml min through a cyano column(5lm 
partical size).The analytes were detected at 215nm. Statistical experimental designs and graphic 
representations (response surface methodologies, Pareto charts )were used for selecting the 
proper detection wavelength, optimizing the mobile phase composition, and assessing method 
robustness. The linearity of the calibration(r>0.99,n1/421) in the relevant ranges (up to 130% of 
the expected concentrations of the analytes in the formulation), method accuracy (bias<2.0%), 
repeatability (RSD<2.0%) and intermediate precision, were verified. In addition, specificity 
(peak purities with photodiode array detector >0.9997) and method robustness were evaluated, 
and system suitability parameters were determined .The validated method was successfully 
employed for the routine analysis of various commercial tablet syrup pharmaceutical  against 
the common cold, showing satisfactory analyte recoveries and RSD values. 
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4. AIM AND PLAN OF WORK 
 
The extensive literature survey carried out revealed few methods have been 
reported for simultaneous estimation of Salbutamol sulphate, Guaifenesin and 
Ambroxol hydrochloride and in combination with other drugs. However there is no 
method reported for the simultaneous estimation of Salbutamol, Guaifenesin and 
Ambroxol hydrochloride  in oral liquid dosage form. So it was felt that there is a need 
to develop RP-HPLC method for the determination of Salbutamol sulphate, 
Guaifenesin and Ambroxol hydrochloride simultaneously in single step process. 
Hence the present work is aimed to develop reverse phase HPLC method for the 
simultaneous determination of Salbutamol sulphate, Guaifenesin and Ambroxol 
hydrochloride in oral liquid dosage form and validation of the developed method. 
 
The plan of the work for the aimed study was designed as follows: 
 
 Method development by RP-HPLC 
 Selection of suitable wavelength 
 Selection of stationary phase 
 Selection of mobile phase 
 Optimization of chromatographic conditions  
               
 Validation of developed method using the following parameters                
o System suitability 
o Accuracy 
o Precision 
 System precision 
 Method precision 
 Intermediate precision 
o Linearity 
o Robustness 
o Specificity 
o Solution stability 
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5. MATERIALS AND METHODS 
Drug samples 
 Salbutamol sulphate, Guaifenesin and Ambroxol hydrocloride raw materials were 
obtained as gift samples from Bioplus Life Sciences Pvt, Ltd, Hosur.    
Formulation used 
 CRMS Syrup (100mL) containing 50 mg/5mL of Guaifenesin, 15 mg/5mL of 
Ambroxol and 1 mg/5mL of Salbutamol, manufactured by Pharmed Ltd., Whitefield road, 
Bangalore was procured from local market.  
Instruments used 
1) HPLC    - agilent / chemstation 
2) Agilent separation module 1200 
3) Injector   -  Auto Injector 
4) Column   - Inertsil C8-3 (250 x 4.6 mm, 5 µ)  
5) Detector   - Agilent DAD or UV detector 
6) pH meter           -         Adwa AD 1020 
7) Jasco               - Double beam UV-VISIBLE spectrophotometer. 
8) Denver              - Analytical  balance (10 mg – 200 gm) 
9) Hot Air Oven    - Techno Lab, model BTZ 
 
Reagents and Chemicals 
1) Sodium dihydrogen phosphate (AR grade) 
2) Triethyl amine(LR grade)  
3) Ortho-phosphoric acid (AR grade)  
4) Acetonitrile (HPLC grade) 
5) Methanol (HPLC Grade) 
6) Water  (Milli Q)  
 Reference Standards  
a. Guaifenesin 
% Purity –99.7% w/w 
b. Ambroxol hydrochloride 
% Purity –99.8% w/w 
c. Salbutamol sulphate 
% Purity –99.8% w/w 
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6. RESULTS AND ANALYSIS 
 
6.1. DEVELPOMENT AND OPTIMIZATION OF CHROMATOGRAPHIC 
PARAMETERS 
6.1.1. Solubility 
 According to literature review, Salbutamol sulphate, Guaifenesin and Ambroxol 
hydrochloride are freely soluble in methanol. Therefore the solubility of the drugs was 
checked with different dilutions of phosphate buffer (pH-3), methanol and acetonitrile. 
Finally buffer: acetonitrile: methanol in the ratio 65:10:25 was chosen as solvent for present 
work. 
6.1.1.2. Selection of chromatographic method 
 The choice of the chromatographic method is based on the nature of the sample (ionic 
or neutral molecule), its molecular weight and solubility. As drugs are polar in nature, the 
reverse phase chromatographic technique was selected for the present study. 
6.1.1.3. Selection of wavelength (max) 
 In setting up the conditions for development of the assay method, the choice of 
detection wavelength was based on the scanned absorption spectrum for Salbutamol, 
Ambroxol and Guaifenesin. The UV- Spectrum of Salbutamol, Ambroxol and Guaifenesin 
were obtained separately.  
 
Figure 3 UV-Spectrum of Salbutamol sulphate 
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Figure 4 UV-Spectrum of Guaifenesin 
 
 
Figure 5 UV-Spectrum of Ambroxol hydrochloride 
 
 
 By scanning the sample solution Salbutamol, Ambroxol and Guaifenesin each 
10µg/mL in methanol over the wavelength range 200-400 nm against blank. After thorough 
examination of the spectra, the wavelength 276 nm was chosen for further analysis. 
 
6.2 METHOD DEVELOPMENT TRIALS 
6.2.1. Sample preparation 
     Salbutamol, Ambroxol and Guaifenesin each 10µg/mL solution in methanol was prepared 
and used for trials. 
Trial – 1 
 The trial 1 was performed with Water: Methanol in the ratio of 50:50%v/v with flow 
rate 1 mL/min. 
 Only two peaks were identified. 
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Trial – 2 
 The trial 2 was performed with Water: Methanol: Acetonitrile in the ratio of 
40:30:30%v/v with flow rate 1 mL/min.  
Only two peaks were obtained. 
 In Water: Methanol and water: Acetonitrile only two peaks were identified. So, 
instead of water, next trails were performed with Sodium dihydrogen Phosphate buffer (pH-
3.0). 
Trial – 3 
  The trial 3 was performed by using Buffer: Acetonitrile: Methanol in the ratio of 
50:25:25%v/v with flow rate 1 mL/min. 
  Only two peaks were eluted (i.e) Salbutamol and Guaifenesin. 
Trial – 4  
 The trial 4 was performed by using Buffer: Acetonitrile: Methanol in the ratio of 
80:10:10%v/v with flow rate 1 mL/min. 
            Only two peaks were eluted (i.e) Guaifenesin and Ambroxol. 
Trial – 5 
           The trial 5 was performed by using Buffer: Acetonitrile: Methanol in the ratio of 
40:30:30%v/v with flow rate 1 mL/min. 
            Only two peaks were eluted (i.e) Salbutamol and Guaifenesin. 
Trial – 6  
           The trial 6 was performed by using Buffer: Acetonitrile: Methanol in the ratio of 
60:5:30%v/v with flow rate 1 mL/min. 
            Only two peaks were eluted (i.e) Salbutamol and Guaifenesin. 
Trial – 7  
           The trial 7 was performed by using Buffer: Acetonitrile: Methanol in the gradient 
method 0-5 mins buffer 100%, 5.1-10 mins buffer 75%: Acetonitrile 15%: Methanol 15%, 
10.1-15 mins buffer 100% with flow rate 1 mL/min. 
            Only two peaks were eluted (i.e) Guaifenesin and Ambroxol. 
Trial – 8  
           The trial 8 was performed by using Buffer: Acetonitrile: Methanol in the gradient 
method 0-4 mins buffer 100%, 4.1-15 mins buffer 65%: Acetonitrile 15%: Methanol 20%, 
15.1-18 mins buffer 100% with flow rate 1 mL/min. 
            Only two peaks were eluted (i.e) Guaifenesin and Ambroxol. 
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Trial – 9  
           The trial 9 was performed by using Buffer: Acetonitrile: Methanol in the gradient 
method 0-10 mins buffer 100%, 10.1-22 mins buffer 65%: Acetonitrile 15%: Methanol 20%, 
22.1-25 mins buffer 100% with flow rate 1 mL/min. 
            Only two peaks were eluted (i.e) Guaifenesin and Ambroxol. 
Trial – 10  
           The trial 10 was performed by using Buffer: Acetonitrile: Methanol in the gradient 
method 0 mins buffer 90%: Acetonitrile 5%: Methanol 5%, 10 mins buffer 86%: Acetonitrile 
7%: Methanol 7%, 14 mins buffer 70% : Acetonitrile 15%: Methanol 15%, 25 mins buffer 
65%: Acetonitrile 15%: Methanol 20%, 28-30 mins buffer 90%: Acetonitrile 5%: Methanol 
5%,  with flow rate 1 mL/min. 
            Only two peaks were eluted (i.e) Guaifenesin and Ambroxol. 
Trial – 11 
 The trial 11 was performed by using Buffer: Acetonitrile: Methanol in the ratio of 
75:20:5%v/v with flow rate 1 mL/min. 
  Interference in Salbutamol and Ambroxol. 
Trial – 12  
 The trial 12 was performed by using Buffer: Acetonitrile: Methanol in the ratio of 
70:15:15%v/v with flow rate 1 mL/min. 
 Interference in Salbutamol and Ambroxol. 
Trial – 13 
 The trial 13 was performed by using Buffer: Acetonitrile: Methanol in the ratio of 
65:15:20%v/v with flow rate 1 mL/min. 
  The retention time of Salbutamol was found to be 3.1, Guaifenesin was eluted in 6.1 
and Ambroxol was eluted in 9.8.  Small hump on Salbutamol peak . 
Trial – 14  
           The trial 14 was performed by using Buffer: Acetonitrile: Methanol in the ratio of 
65:10:25%v/v with flow rate 1 mL/min. 
 The retention time of Salbutamol, Guaifenesin and Ambroxol was found to be 3.2, 9.8 
and 11.8mins respectively. 
Conclusion 
 Out of the 14 trials, the 14th trial was selected for further studies.  When compared to 
the other trials the in the 14th trial has good plate count, Tailing factor, Symmetry and 
Resolution observed and peak shape was also good. 
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6.3 OPTIMIZED CHROMATOGRAPHIC CONDITIONS 
           Stationary Phase :  Inertsil C8-3 (250 mmx4.6 mm , 5 µ) 
           Separation module :  Agilent 1200 
           Injector    :  Auto injector 
           Flow rate   :  1.0 mL/min 
           Operating temperature :  Ambient 
           Selected wave length  :  276 nm 
          Mobile phase ratio  :  Buffer: Acetonitrile: Methanol (65:10:25 %v/v) 
          Diluents   :  Mobile Phase 
          Injection Volume  :  10 µL 
          Run Time    :  25 min 
 
6.4 PREPARATION OF SOLUTIONS 
6.4.1. Preparation of Phosphate buffer 
            Weighed 1.56 grams of NaH2PO4 into a 1000ml beaker, dissolved and to 1000 mL 
with water, add 3 mL of TEA and  adjusted the pH to 3.0 with Ortho-phosporic acid. 
6.4.2. Preparation of mobile phase 
 Mix a mixture of above buffer 650 mL (65%), 100 mL of Acetonitrile (10%) and 250 
mL of Methanol (25%) degassed in ultrasonic water bath for 5 minutes. Filtered through 
0.45µ filter under vacuum filtration.  
6.4.3. Standard solution  
Preparation of Salbutamol, Ambroxol and Guaifenesin stock solution: 
  Accurately weighed quantity of 500 mg of Guaifenesin, 150 mg Ambroxol and 25 mg 
of Salbutamol was transferred to three different 100 mL volumetric flask, dissolved in 25 mL 
of mobile phase, sonicated for 5 min and the volume was made up with mobile phase.  
6.4.4. Concentration of stock solution 
Guaifenesin   - 500 µg/mL  
Ambroxol hydrochloride - 150 µg/mL 
Salbutamol sulphate   - 10 µg/mL 
 
6.4.5. Preparation of working standard 
            Working standard for Guaifenesin, Ambroxol and Salbutamol were prepared by 
pipetting 10 mL, 10mL  and 4 mL respectively from each of the stock solution in a 100 mL 
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volumetric flasks and the volume was made up with the mobile phase to give the following 
concentration.  
Guaifenesin   - 500 µg/mL 
Ambroxol hydrochloride - 150 µg/mL 
Salbutamol sulphate   - 10 µg/mL 
 
6.4.6. Sample preparation 
 Accurately measure, amount equivalent to 500 mg of Guaifenesin, 150 mg of 
Ambroxol and 25 mg of salbutamol from liquid formulation was accurately weighed and 
taken in three different 100 mL volumetric flask and 25 mL of mobile phase was added. The 
mixture was subjected to sonication for 15 min with intermediate shaking for complete 
dissolving of drugs. Cooled to room temperature and the solution was made up to the mark 
with mobile phase. Filtered using 0.45µ filter. Then 10 μL of this solution was injected for 
HPLC analysis. 
 
6.4.7. Procedure 
 Separately blank, standard and test solutions were injected and the areas for major 
peaks were recorded for Guaifenesin, Ambroxol and Salbutamol and % assay was calculated 
by using the following formula.                    
       AT     x    WS    x     DT    x     P    x     Avg. Wt 
                                                                                             X 100 
       AS     x     DS    x     WT    x    100 x     Label Claim 
Where:  
 AT = average area counts of sample preparation. 
            As = average area counts of standard preparation. 
            WS = Weight of working standard taken in mg. 
            WT = Weight of test taken in mg. 
            DS = Standard dilution 
            DT = Test dilution 
            P    = Percentage purity of working standard  
            LC = label claim mg/mL.       
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6.5. METHOD VALIDATION 
 
6.5.1. Introduction: 
  
The method has been validated for Salbutamol sulphate, guaifenesin and ambroxol 
hydrochloride (CRMS Syrup) by following validation parameters, 
 The method validation involves establishing of the following parameters 
a. System suitability 
b. Accuracy  
c. Precision  
i. System Precision/Repeatability 
ii. Method Precision 
iii. Intermediate Precision/Ruggedness 
d. Linearity  
e. Robustness  
f. Specificity  
g. Solution stability 
6.5.2. System suitability studies 
 Salbutamol sulphate, Guaifenesin and Ambroxol hydrochloride solutions were 
prepared and injected. Then the system suitability parameters like Resolution, Retention 
Time, plate number (N), Peak asymmetry factor (Tailing) were evaluated with the help of 
standard chromatogram. 
Table 4 Results for System suitability Parameters 
Parameters 
Salbutamol 
sulphate 
Guaifenesin 
Ambroxol  
hydrochloride 
Acceptance 
criteria 
Resolution NA 29.90 4.69 NLT 2 
Tailing factor 1.1 1.1 1.3 NLT 2 
Number of 
theoretical plate 
14133 13119 
9978 NLT 2000 
Retention time 3.157 9.949 11.883 NA 
 
6.5.3. Accuracy 
 Accuracy expresses the closeness of agreement between the value, which is accepted 
either as conventional true value or and accepted reference value (International Standard e.g. 
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Pharmacopoeia Standard) and the value found (mean value) obtained by applying the test 
procedure a number of times. 
  The recovery study was carried out at 50%, 100% and 150% level and the contents 
were determined from the respective chromatogram. From the results obtained we can 
conclude that the method was accurate 
Table 5 Results for Recovery Study for Salbutamol 
 
Accuracy 
Level 
Amount of 
Salbutamol 
Added 
(µg) 
Amount of 
Salbutamol 
Found 
(µg) 
 
% 
Recovery 
 
% Mean 
Recovery 
 
 
SD 
 
% 
RSD 
 
Accuracy solution 
  50%-1 
 
 
 
4.99 
4.91 101.6  
 
 
101.5 
 
 
 
0.23 
 
 
 
0.23 
Accuracy solution 
50%-2 
4.93 101.2 
Accuracy solution 
50%-3 
4.91 101.6 
Accuracy solution 
100%-1 
 
 
 
9.98 
9.87 101.1  
 
 
101.3 
 
 
 
0.15 
 
 
 
0.15 
Accuracy solution 
100%-2 
9.85 101.3 
Accuracy solution 
100%-3 
9.84 101.4 
Accuracy solution 
150%-1 
 
 
 
14.97 
14.78 101.3  
 
101.2 
 
 
0.15 
 
 
0.15 Accuracy solution 
150%-2 
14.82 101.0 
Accuracy solution 
150%-3 
14.79 101.2 
 
Acceptance Criteria: The % Recovery for each level should be between 98.0% to 102.0%. 
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Table 6 Results for Recovery Study for Guaifenesin 
 
 
Accuracy 
Level 
Amount of 
Guaifenesin 
Added (µg) 
Amount of 
Guaifenesin 
Found (µg) 
 
% 
Recovery 
 
% Mean 
Recovery 
 
 
SD 
 
% 
RSD 
Accuracy solution 
50%-1 
 
 
 
249.25 
252.65 98.7  
 
98.7 
 
 
0.15 
 
 
0.15 Accuracy solution 
50%-2 
253.12 98.5 
Accuracy solution 
50%-3 
252.16 98.8 
Accuracy solution 
100%-1 
 
 
 
498.50 
504.58 98.7  
 
98.5 
 
 
0.20 
 
 
0.20 Accuracy solution 
100%-2 
505.85 98.5 
Accuracy solution 
100%-3 
507.25 93.3 
Accuracy solution 
150%-1 
 
 
 
747.75 
758.12 98.6  
 
98.4 
 
 
0.21 
 
 
0.21 Accuracy solution 
150%-2 
760.85 98.3 
Accuracy solution 
150%-3 
761.65 98.2 
 
Acceptance Criteria: The % Recovery for each level should be between 98.0% to 102.0%. 
 
Table 7 Results for Recovery Study for Ambroxol 
 
 
Accuracy 
Level 
Amount of 
Ambroxol 
hydrochloride 
Added (µg) 
Amount of 
Ambroxol 
hydrochloride 
Found (µg) 
 
% 
Recovery 
 
%  
Mean 
Recovery 
 
 
SD 
 
% 
RSD 
 
Accuracy solution 
50%-1 
 
 
74.85 
74.15 100.6  
 
100.5 
 
 
0.25 
 
 
0.25 Accuracy solution 
50%-2 
73.89 100.9 
Accuracy solution 
50%-3 
74.25 100.4 
Accuracy solution 
100%-1 
 
 
149.70 
148.42 100.8  
 
100.6 
 
 
0.26 
 
 
0.26 Accuracy solution 
100%-2 
148.62 100.7 
Accuracy solution 
100%-3 
149.12 100.3 
Accuracy solution 
150%-1 
 
 
224.55 
222.58 100.9  
 
100.7 
 
 
0.15 
 
 
0.15 Accuracy solution 
150%-2 
222.96 100.7 
Accuracy solution 
150%-3 
223.16 100.6 
 
Acceptance Criteria: The % Recovery for each level should be between 98.0% to 102.0%. 
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6.5.4. Precision 
6.5.4.1. System Precision/Repeatability of Injection 
The system precision was performed by injecting standard solution for five times on 
to the analytical column and the peak area was measured then %RSD for the area of five 
replicate injections was calculated.  
Table 8 Results for System Precision of Salbutamol sulphate, Guaifenesin and 
Ambroxol hydrochloride 
S. No 
Area of  Salbutamol 
sulphate 
 
Area of Guaifenesin 
 
Area of 
Ambroxol 
hydrochloride 
1 38.112 3488.011 214.053 
2 38.998 3498.539 216.653 
3 38.620 3507.698 214.790 
4 38.148 3506.391 215.290 
5 38.613 3510.320 216.647 
Mean 38.498 3502.012 215.491 
S.D 0.37 9.06 1.15 
%RSD 1.0 0.3 0.5 
Acceptance Criteria: The %R SD should be NMT 2.0% 
6.5.4.2. Method Precision 
The method precision was done by performing assay on six replicate determination 
of sample preparation at test concentration level (as per method of analysis) and the relative 
standard deviation of assay results was obtained. 
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Table 9 Results for Method Precision of Salbutamol sulphate, Guaifenesin and 
Ambroxol hydrochloride 
 
S.No 
Area of 
Salbutamol 
sulphate 
% Assay 
Area of 
Guaifenesin 
% Assay 
Area of 
Ambroxol 
hydrochloride 
 
%Assay 
1 38.011 101.86 3556.132 98.43 214.985 100.28 
2 38.108 101.56 3552.128 98.54 214.856 100.34 
3 38.214 101.31 3553.563 98.49 214.988 100.28 
4 38.256 101.20 3557.256 98.39 215.011 100.27 
5 38.302 101.08 3554.982 98.46 215.141 100.21 
6 38.359 100.93 3557.211 98.39 215.210 100.18 
Mean 38.211 101.32 3555.212 98.45 215.032 100.26 
SD 0.13 0.34 2.06 0.06 0.12 0.06 
%RSD 0.33 0.33 0.06 0.06 0.06 0.06 
Acceptance Criteria: The %RSD should be NMT 2.0% 
6.5.4.3. Intermediate Precision/Ruggedness 
           To evaluate the intermediate precision (also known as Ruggedness) of the method,   
Precision was performed on different day by using different make column of same 
dimensions.  
Table 10 Results for Intermediate Precision of Salbutamol sulphate, Guaifenesin and 
Ambroxol hydrochloride 
 
S.No 
Area of 
Salbutamol 
sulphate 
% Assay 
Area of 
Guaifenesin 
% 
Assay 
Area of 
Ambroxol 
hydrochloride 
 
%Assay 
1 38.154 101.47 3561.012 98.29 214.654 100.44 
2 38.210 101.33 3563.254 98.23 214.852 100.35 
3 38.245 101.23 3568.453 98.09 214.741 100.39 
4 38.311 101.06 3559.245 98.34 214.998 100.28 
5 38.345 100.97 3560.854 98.29 215.014 100.27 
6 38.352 100.95 3562.852 98.24 214.961 100.29 
Mean 38.269 101.17 3562.61 98.25 214.870 100.34 
SD 0.08 0.21 3.21 0.09 0.15 0.07 
%RSD 0.21 0.31 0.09 0.09 0.07 0.07 
Acceptance Criteria: The %RSD should be NMT 2.0 
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6.5.5. Linearity and Range 
6.5.5.1. Preparation of Level – I   
        5mL, 5mL and 2mL of stock solution for Salbutamol, Guaifenesin and Ambroxol were 
taken in 100mL of volumetric flask diluted up to the mark with mobile phase.  
  
6.5.5.2. Preparation of Level – II  
         7.5mL, 7.5mL and 3mL of stock solution for Salbutamol, Guaifenesin and Ambroxol 
were taken in 100mL of volumetric flask diluted up to the mark with mobile phase.  
 
6.5.5.3. Preparation of Level – III  
           10mL, 10mL and 4mL of stock solution for Salbutamol, Guaifenesin and Ambroxol 
were taken in 10mL of volumetric flask diluted up to the mark with mobile phase. 
 
6.5.5.4. Preparation of Level – IV  
            12.5mL, 12.5mL and 5mL of stock solution for Salbutamol, Guaifenesin and 
Ambroxol were taken in 10mL of volumetric flask diluted up to the mark with mobile phase. 
 
6.5.5.5. Preparation of Level – V  
           15mL, 15ml and 6mL of stock solution for Salbutamol, Guaifenesin and Ambroxol 
were taken in 10mL of volumetric flask diluted up to the mark with mobile phase. 
 
6.5.5.6. Procedure 
           Solution of   each level was injected into the chromatographic system and the peak 
area was measured.           
Salbutamol sulphate showed linearity in the range of 5-15 (µg/mL), Guaifenesin 
showed linearity in the range of 250-750 (µg/mL) and Ambroxol hydrochloride showed 
linearity in the range of 75-225 (µg/mL).The calibration graphs was plotted with peak area in 
the Y axis and concentration of standard solution in the X axis. The degree of linearity was 
estimated by calculating the correlation coefficient. 
The correlation coefficient values for Salbutamol sulphate, Guaifenesin and 
Ambroxol hydrochloride were found to be respectively. 
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Table 11 Results for Linearity Data 
Concentration 
of 
Salbutamol 
sulphate 
(µg/mL) 
Peak Area 
Concentration 
of 
Guaifenesin 
(µg/mL) 
 
Peak Area 
 
Concentration 
of Ambroxol 
hydrochloride 
(μg/ml) 
 
 
Peak Area 
05 20.298 250 1784.443 75 110.443 
7.5 30.306 375 2676.681 112.5 166.149 
10 39.608 500 3520.368 150 220.646 
12.5 48.196 625 4422.826 187.5 272.420 
15 57.828 750 5267.516 225 326.137 
Correlation coefficient - 
0.9994 
Correlation coefficient - 
0.9999 
Correlation coefficient - 
0.9998 
Acceptance Criteria: The correlation coefficient should be NLT 0.99 
Figure6 Linearity Plot for Salbutamol sulphate 
 
 
 
Figure 7 Linearity Plot for Guaifenesin 
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    Figure 8 Linearity Plot for Ambroxol hydrochloride 
 
 
6.5.6. Robustness 
          For demonstrating the robustness of the developed method, experimental conditions 
were purposely altered and evaluated. The method must be robust enough to withstand such 
slight changes and allow routine analysis of the sample. Following optimized conditions were 
slightly varied. 
 6.5.6.1. Effect of Flow rate 
 Robustness of assay method was carried out with variation of flow rate ±0.1mL/min of 
the set value i.e. 1mL/min. Standard solution was prepared and performed analysis as per test 
method and evaluated the system suitability parameters. 
Table 12 Results for effect of Flow rate 
Name Flow rate 
mL/Min 
RT Plate count Tailing Resolution 
Salbutamol 
sulphate 
0.9 3.49 11482 0.8 NA 
1.0 3.15 14133 1.1 NA 
1.1 2.80 10403 0.8 NA 
Guaifenesin 0.9 10.88 13848 1.1 29.52 
1.0 9.94 13119 1.1 29.90 
1.1 9.01 12690 1.1 28.52 
Ambroxol 
hydrochloride 
0.9 12.86 10421 1.3 4.52 
1.0 11.88 9978 1.3 4.69 
1.1 10.93 9477 1.3 4.48 
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Table 13 Results for  change in flow rate (0.9 ml/Min) 
S. No 
Area of  Salbutamol 
sulphate 
 
Area of Guaifenesin 
 
 
Area of 
Ambroxol 
hydrochloride 
1 38.011 3488.011 214.053 
2 38.108 3498.539 216.653 
Mean 38.056 3493.275 215.353 
S.D 0.07 7.44 1.84 
%RSD 0.18 0.21 0.85 
 Acceptance Criteria : %RSD should be NMT 2 
Table 14 Results for change in flow rate (1.0 mL) 
S. No 
Area of  Salbutamol 
sulphate 
 
Area of Guaifenesin 
 
 
Area of 
Ambroxol 
hydrochloride 
1 38.684 3506.425 215.243 
2 38.298 3510.122 215.987 
Mean 38.491 3508.274 215.615 
S.D 0.27 2.61 0.54 
%RSD 0.71 0.07 0.24 
Acceptance Criteria : %RSD should be NMT 2  
Table 15 Results for  change in flow rate (1.1 mL/Min) 
S. No 
Area of  Salbutamol 
sulphate 
 
Area of Guaifenesin 
 
 
Area of 
Ambroxol 
hydrochloride 
1 37.854 3486.218 213.458 
2 38.024 3488.452 213.853 
Mean 37.939 3487.335 213.655 
S.D 0.12 1.58 0.28 
%RSD 0.32 0.05 0.13 
Acceptance Criteria : %RSD should be NMT 2  
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6.5.6.2. Effect of Wavelength 
 Robustness of assay method was carried out with variation of wavelength ±2nm of the 
set value i.e. 276nm. Standard solution was prepared and performed analysis as per test 
method and evaluated the system suitability parameters. 
Table 16 Results for effect of Wavelength 
Name 
Wavelength 
(nm) 
RT Plate count Tailing Resolution 
Salbutamol 
sulphate 
274 3.56 11882 0.8 NA 
276 3.15 14133 1.1 NA 
278 2.86 11403 0.8 NA 
Guaifenesin 274 10.98 12848 1.1 29.22 
276 9.94 13119 1.1 29.90 
278 9.31 11690 1.1 28.98 
Ambroxol 
hydrochloride 
274 12.46 10521 1.3 4.82 
276 11.88 9978 1.3 4.69 
278 11.13 9677 1.3 4.28 
 
Table 17 Results for change in wavelength (274nm) 
S. No 
Area of  Salbutamol 
sulphate 
 
Area of Guaifenesin 
 
Area of 
Ambroxol 
hydrochloride 
1 39.021 3504.258 216.687 
2 39.254 3508.654 216.458 
Mean 39.138 3506.456 216.573 
S.D 0.16 3.11 0.16 
%RSD 0.42 0.09 0.07 
Acceptance Criteria : %RSD should be NMT 2  
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Table 18 Results for change in wavelength 276nm 
S. No 
Area of  Salbutamol 
sulphate 
 
Area of Guaifenesin 
 
Area of 
Ambroxol 
hydrochloride 
1 38.698 3498.254 215.124 
2 38.386 3501.568 215.354 
Mean 38.542 3499.911 215.239 
S.D 0.22 2.34 0.16 
%RSD 0.57 0.07 0.08 
Acceptance Criteria : %RSD should be NMT 2 
Table 19 Results for change in wavelength (278nm) 
S. No 
Area of  Salbutamol 
sulphate 
 
Area of Guaifenesin 
 
Area of 
Ambroxol 
hydrochloride 
1 38.054 3488.478 214.689 
2 38.114 3492.854 214.287 
Mean 38.084 3490.666 214.488 
S.D 0.04 3.09 0.28 
%RSD 0.11 0.09 0.13 
Acceptance Criteria : %RSD should be NMT 2 
6.5.7. Specificity 
  In case of simultaneous assay of Salbutamol sulphate, Guaifenesin and Ambroxol 
hydrochloride, demonstration of specificity requires that the procedure is unaffected by the 
presence of impurities or excipients. 
            This comparison should include samples stored under relevant stress conditions. 
Table 20 Results for Peak purity 
 
Name 
Retention Time  
Peak Purity Salbutamol 
sulphate 
Guaifenesin 
Ambroxol 
hydrochloride 
Blank Not detected Not detected Not detected NA 
Placebo Not detected Not detected Not detected NA 
Standard 3.13 9.99 11.88 1.1 
Control Sample 3.14 9.95 11.86 1.1 
Acceptance Criteria : Peak purity should be not less than 1 
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Table 21 Results for %Assay 
Name 
Lable claim 
(mg) 
Amount found 
(mg) 
% Assay 
 
Salbutamol sulphate 
 
1 
 
1.01 
 
101.00 
 
Guaifenesin 
 
50 
 
 
49.68 
 
99.36 
 
Ambroxol 
hydrochloride 
 
15 
 
14.98 
 
99.87 
Acceptance Criteria : % Assay should be between 98% to 102% 
 
6.5.9. Solution Stability 
Standard solution was prepared as per the test method and stored at room temperature 
(230C-270C). Solution stability study to be performed at different days, against freshly 
prepared standard solution. 
 
Table 22 Results for Standard solution stability 
 
Interval 
Room Temperature (230C-270C) 
Salbutamol 
Area 
Guaifenesin 
Area 
Ambroxol 
Area 
Similarity factor 
Salbutamol Guaifenesin Ambroxol 
Initial 38.620 3507.698 214.790 1.01 1.00 1.00 
24 Hrs 37.557 3497.494 213.358 1.00 1.01 1.01 
36 Hrs 38.998 3526.216 215.165 0.99 1.01 1.01 
48 Hrs 40.356 3598.583 216.639 1.01 1.00 1.00 
Acceptance Criteria: The similarity factor  should be 0.98-1.02 
 
 Sample  solution was prepared as per the test method and stored at room temperature 
(230C-270C). Solution stability study to be performed at different days, against freshly 
prepared Sample solution.  
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Table 23 Results for Sample solution stability 
 
 Interval 
Room Temperature (230C-270C) 
SAB 
Area 
GUA 
Area 
 
AMB 
Area 
% Assay Absolute % 
Difference 
SAB 
 
GUA AMB SAB GUA AMB 
Initial 38.256 3557.256 215.011 101.58 99.56 100.88 NA NA NA 
24 Hrs 38.557 3602.494 214.058 101.15 99.15 100.56 0.4 0.4 0.3 
36 Hrs 39.987 3687.216 214.665 100.96 98.56 100.05 0.2 0.6 0.5 
48 Hrs 40.998 3714.583 216.139 100.85 98.21 99.87 0.1 0.3 0.2 
Acceptance Criteria: The absolute % difference should be NMT 1.0 
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7. CHROMATOGRAMS 
System suitability: 
Plate Count 
 
Tailing   
Salbutamol sulphate 
 
Guaifenesin 
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Ambroxol hydrochloride 
 
Accuracy 
Level 50%-1_1 
 
Level 50%-1_2 
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Level 50%-2_1 
 
Level 50%-2_2 
 
Level 50%-3_1 
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Level 50%-3_2 
 
Level 100%-1_1 
 
Level 100%-1_2 
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Level 100%-2_1 
 
Level 100%-2_2 
 
Level 100%-3_1 
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Level 100%-3_2 
 
Level 150%-1_1 
 
Level 150%-1_2 
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Level 150%-2_1 
 
Level 150%-2_2 
 
Level 150%-3_1 
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Level 150%-3_2 
 
Precision 
1. System Precision 
Standard_1 
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Standard_2 
 
Standard_3 
 
Standard_4 
 
Chapter 7                                                                                                            Chromatograms 
 
Nandha college of Pharmacy & Research Institute 76 
 
Standard_5 
 
2. Method precision 
Method precision-1_1 
 
Method precision-1_2 
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Method precision -2_1 
 
Method precision-2_2 
 
Method precision-3_1 
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Method precision-3_2 
 
Method precision-4_1 
 
Method precision-4_2 
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Method precision-5_1 
 
Method precision-5_2 
 
Method precision-6_1 
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Method precision-6_2 
 
Intermediate Precision 
Intermediate precision-1_1 
 
Intermediate precision-1_2 
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Intermediate precision-2_1 
 
Intermediate precision-2_2 
 
Intermediate precision-3_1 
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Intermediate precision-3_2 
 
Intermediate precision-4_1 
 
Intermediate precision-4_2 
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Intermediate precision-5_1 
 
Intermediate precision-5_2 
 
Intermediate precision-6_1 
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Intermediate precision-6_2 
 
Linearity 
Level 1-50% 
 
Level 2-75% 
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Level 3-100% 
 
Level 4-125% 
 
Level 5-150% 
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Robustness 
Flow minus_Standard (0.9mL/Min) 
 
Flow minus_Sample (0.9mL/Min) 
 
Flow plus_Standard (1.1mL/Min) 
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Flow plus_Sample (1.1mL/Min) 
 
Specificity 
Blank 
 
Placebo 
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Standard_Salbutamol sulphate 
 
Standard_Guaifenesin 
 
Standard_Ambroxol hydrochloride 
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Control Sample 
 
Peak Purity 
Salbutamol sulphate 
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Guaifenesin 
 
Ambroxol hydrochloride 
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Solution stability 
Standard_Initial 
 
Standard_24Hrs 
 
Standard_36Hrs 
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Standard_48Hrs 
 
Sample_Initial 
 
Sample_24Hrs 
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Sample_36Hrs 
 
Sample_48Hrs 
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8. DISCUSSION 
8.1 Method development 
         Several mobile phase compositions were tried to get good optimum resolutions of 
Salbutamol sulphate, Guaifenesin and Ambroxol hydrochloride peaks. The mobile phase 
containing Sodium dihydrogen phosphate buffer+TEA (pH3.0):Acetonitrile:Methanol 
(65:10:25 %v/v) was selected because it gave sharp peaks with good resolution, minimum 
tailing and satisfactory retention time. Both the drugs having appreciable absorbance at 
276nm and therefore 276nm was selected as the detection wavelength. 
The working standard solutions of Salbutamol sulphate, Guaifenesin and Ambroxol 
hydrochloride were injected separately. The retention time of Salbutamol sulphate, 
Guaifenesin and Ambroxol hydrochloride was found to be 3.157min, 9.949min and 
11.883min respectively when injected as individual compounds. 
8.2 Validation of the method 
          The system suitability parameters were studied from the chromatogram to ascertain 
the suitability of the proposed method. The number of theoretical plates was found to be 
14133 for Salbutamol and 13119 for Guaifenesin and 9978 for Ambroxol indicating the 
suitability of the method. The tailing factor was found to be 1.1 for Salbutamol and 1.1 for 
Guaifenesin and 1.3 for Ambroxol indicating good symmetry. The obtained resolution 
between Salbutamol and Guaifenesin was 29.90 and between Guaifenesin and Ambroxol 
was 4.69 indicating good and complete separation of three drugs (presented in table 4). 
         The accuracy of the method was determined by recovery experiments. The recovery 
study was carried out at 50%, 100% and 150% level. The percentage recovery and mean 
percentage of the recovery were calculated. The results showed percentage recovery of 
100.5% to 101.6% for Salbutamol and 98.4% to 98.8% for Guaifenesin and 100.1% to 
100.8% for Ambroxol was in agreement to the acceptance criteria 98% to 102%. From the 
data obtained, the recoveries of standard drugs were found to be accurate (presented in table 
5&6&7). 
        The precision of system and method was determined by replicate injections of 
standard drug solution. In the system precision the %RSD of peak area was found to be 1.0 
for Salbutamol and 0.3 for Guaifenesin and 0.5 for Ambroxol. In the method precision the 
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%RSD of assay was found to be 0.3 for Salbutamol and 0.06 for Guaifenesin and 0.06 for 
Ambroxol. The values of %RSD for precision study obtained were well within the 
acceptance criteria less than 2%. Thus the method providing high degree of precision 
(presented in table 8&9). 
        To evaluate the intermediate precision (also known as Ruggedness) of the method,   
Precision was performed on different day by using different make column of same 
dimensions. The %RSD of peak area was found to be 0.2 for Salbutamol and 0.09 for 
Guaifenesin and 0.07 for Ambroxol (presented in table 10). Thus the results were found to 
be highly reproducible in spite of variations in the conditions. 
       To evaluate the linearity of method, the standard drug solutions of varying 
concentrations ranging from 50 % to 150 % of the targeted level of the assay concentration 
were examined by the proposed method. The peak area and concentration were plotted to 
get a standard calibration curve. The correlation coefficient was found to be 0.9994 for 
Salbutamol and 0.9999 for Guaifenesin and 0.9998 for Ambroxol. The linearity was 
obtained in the concentration range of 5-15 μg/mL Salbutamol and 250-750 μg/mL for 
Guaifenesin and 75-125 μg/mL for Ambroxol (presented in table 11). The calibration graph 
shows that linear response was obtained over the range of concentrations used in the assay 
procedure. The obtained data demonstrates that the methods have adequate sensitivity to the 
concentrations of the analytes. The range demonstrates that the method is linear outside the 
limits of expected use.  
              The robustness of the method was studied by carrying out experiments by 
changing experimental conditions flow rate and wavelength ratio. No significant effect on 
chromatographic resolution was seen and hence the developed method is said to be robust 
(shown on table 12-19). 
        The specificity of the method was studied by the values obtained while sample stored 
under relevant stress conditions. The procedure was unaffected by the presence of 
impurities (shown on table20&21). 
The solution stability of the method, the standard and sample solutions were 
prepared vand injected for several days and check the similarity factor for standard solution 
and absolute % difference for sample solution. The similarity factor for standard solution 
were found to be, Initially 1.01, after 24 Hrs 1.00, after 36 Hrs 0.99 and after 48 Hrs 1.01 
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for Salbutamol and  Initially 1.00, after 24 Hrs 1.01, after 36 Hrs 1.01 and after 48 Hrs 1.00 
for Guaifenesin and Initially 1.00, after 24 Hrs 1.01, after 36 Hrs 1.01 and after 48 Hrs 1.00 
for Ambroxol. The values for solution stability of standard was within the limit of 0.98-
1.02. Thus, the solution stability of standard passes (shown on table 22). The absolute % 
difference for sample solution were found to be, Initially NA, after 24 Hrs 0.4, after 36 Hrs 
0.2 and after 48 Hrs 0.1 for Salbutamol and Initially NA, after 24 Hrs 0.4, after 36 Hrs 0.6 
and after 48 Hrs 0.3 for Guaifenesin and Initially NA, after 24 Hrs 0.3, after 36 Hrs 0.5 and 
after 48 Hrs 0.2 for Ambroxol. The values for solution stabily of sample was within the 
limit of . Thus, the solution stability of sample passes (shown on table 23).  
Table 24 Validation data 
Parameters 
Salbutamol 
Sulphate 
Guaifenesin 
Ambroxol 
hydrochloride 
Accuracy 
% Recovery = 
101.2 
% Recovery =  
98.6 
% Recovery = 
100.5 
Linearity R2 = 0.9994 R2 = 0.9999 R2 = 0.9998 
Range 05-15 µg/mL 250-750 µg/mL 75-225 µg/mL 
System 
Precision 
%RSD = 1.0 %RSD = 0.3 %RSD = 0.5 
Method precision %RSD = 0.3 %RSD = 0.06 %RSD = 0.06 
Intermediate precision %RSD=0.21 %RSD=0.09 %RSD=0.07 
Robustness (Effect of 
flow) 
%RSD=0.71 %RSD=0.07 %RSD=0.24 
Robustness (Effect of 
wavelength) 
%RSD=0.57 %RSD=0.07 %RSD=0.08 
Solution 
stability 
Standard 
Similarity 
factor=1.01 
Similarity 
factor=1.01 
Similarity 
factor=1.01 
Sample % difference=0.2 % difference=0.4 % difference=0.4 
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8.3 Application of the method for assay of sample 
        The method was applied for the assay of sample i.e. marketed liquid dosage 
form of Salbutamol sulphate, Guaifenesin and Ambroxol hydrochloride. The average 
amount of Salbutamol sulphate, Guaifenesin and Ambroxol hydrochloride present in 
marketed oral liquid dosage form was found to be 1.01mg, 49.68mg and 14.98mg 
respectively. Label claim for Salbutamol 1mg, Guaifenesin 50mg and that of 
Ambroxol hydrochloride 15mg. 
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9. SUMMARY AND CONCLUSION 
          A RP-HPLC method was developed with mobile phase system Sodium dihydrogen 
phosphate buffer pH 3.0: Acetonitrile: Methanol in the ratio of 65:10:25 with the flow rate 
of 1 mL/min. Detection was carried out at 276 nm. Quantitation was done by external 
standard method with the above mentioned optimized chromatographic condition. This 
system produced sharp peaks with good resolution, minimum tailing and satisfactory 
retention times of Salbutamol sulphate, Guaifenesin and Ambroxol hydrochloride were 
found to be 3.157, 9.949 and 11.883 minutes respectively indicating the suitability of 
system. 
         The developed method was validated for various parameters accuracy, precision, 
linearity, robustness, specificity and solution stability as per ICH guidelines. 
         The accuracy of the method was in agreement to the acceptance criteria. The results 
indicate satisfactory accuracy of the method. 
         Precision of the developed method was studied under system precision, method 
precision and intermediate precision. The %RSD values for precision was found to be 
within the acceptable limit, which revealed that the developed method was precise. 
        The linearity was obtained in the concentration range of 5-15 μg/mL Salbutamol 
sulphate, 250-750 μg/mL for Guaifenesin and 75-225 μg/mL. The correlation coefficient 
was found to be 0.9994 for Salbutamol, 0.9999 for Guaifenesin and 0.9998 for Ambroxol 
hydrochloride which indicates excellent correlation between response factor Vs 
concentration of standard solutions.  
         The robustness of the method was studied. The results indicate that the method was 
robust and did not show significant effect on chromatographic resolution.  
         The specificity of the method was studied by the values obtained while sample 
stored under relevant stress conditions. The procedure was unaffected by the presence of 
impurities. 
         The method was applied for the assay of sample i.e. marketed tablet dosage form of 
Salbutamol sulphate, Guaifenesin and Ambroxol hydrochloride. The assay results 
conformed to the label claim of the dosage form.  
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         The developed method has the following advantages when compared to reported 
methods: 
 No tedious extraction procedure required. 
 Suitable for analysis of raw materials and formulations. 
 Indicates stability of the drugs. 
Hence the developed method for simultaneous estimation of Salbutamol sulphate, 
Guaifenesin and Ambroxol hydrochloride said to be rapid, simple, accurate, precise, 
sensitive, robust and specific that can be successfully applied for the routine analysis of 
Salbutamol sulphate, Guaifenesin and Ambroxol hydrochloride in their marketed oral 
liquid dosage form. 
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